| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 3.28e-08 | 37 | 276 | 8 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 4.11e-08 | 38 | 276 | 8 | GO:0070001 | |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 2.10e-07 | 11 | 276 | 5 | GO:0004523 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 1.07e-05 | 37 | 276 | 6 | GO:0016891 | |
| GeneOntologyMolecularFunction | benzodiazepine receptor binding | 2.56e-05 | 5 | 276 | 3 | GO:0030156 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 3.21e-05 | 14 | 276 | 4 | GO:0003964 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 3.89e-05 | 46 | 276 | 6 | GO:0016893 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 1.11e-04 | 79 | 276 | 7 | GO:0004521 | |
| GeneOntologyMolecularFunction | RNA nuclease activity | 1.17e-04 | 136 | 276 | 9 | GO:0004540 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 1.68e-04 | 38 | 276 | 5 | GO:0034061 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 1.78e-04 | 21 | 276 | 4 | GO:0035613 | |
| GeneOntologyMolecularFunction | cGMP-dependent protein kinase activity | 1.90e-04 | 2 | 276 | 2 | GO:0004692 | |
| GeneOntologyMolecularFunction | glycerol-3-phosphate dehydrogenase (quinone) activity | 1.90e-04 | 2 | 276 | 2 | GO:0004368 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor | 1.90e-04 | 2 | 276 | 2 | GO:0016901 | |
| GeneOntologyMolecularFunction | cyclic nucleotide binding | 1.91e-04 | 39 | 276 | 5 | GO:0030551 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | DENND4A MYO9A TBC1D5 SIPA1L3 OBSCN CHML DOCK6 SEC23A RALGDS IQSEC3 RASA3 RALGAPB RAPGEF4 PLEKHG2 TBC1D17 ARFGAP2 DOCK7 RACGAP1 | 2.62e-04 | 507 | 276 | 18 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | DENND4A MYO9A TBC1D5 SIPA1L3 OBSCN CHML DOCK6 SEC23A RALGDS IQSEC3 RASA3 RALGAPB RAPGEF4 PLEKHG2 TBC1D17 ARFGAP2 DOCK7 RACGAP1 | 2.62e-04 | 507 | 276 | 18 | GO:0030695 |
| GeneOntologyMolecularFunction | endonuclease activity | 6.17e-04 | 136 | 276 | 8 | GO:0004519 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on RNA | ERVK-6 ERN1 ERVK-7 ERVK-10 LRRC47 NUDT12 DDX60 EXOSC3 APEX1 LARS2 YARS1 G3BP1 ERVK-8 QTRT1 CNOT1 | 7.40e-04 | 417 | 276 | 15 | GO:0140098 |
| GeneOntologyMolecularFunction | glucosidase activity | 1.05e-03 | 15 | 276 | 3 | GO:0015926 | |
| GeneOntologyBiologicalProcess | cell-cell fusion | 2.05e-06 | 85 | 276 | 9 | GO:0140253 | |
| GeneOntologyBiologicalProcess | syncytium formation by plasma membrane fusion | 2.05e-06 | 85 | 276 | 9 | GO:0000768 | |
| GeneOntologyBiologicalProcess | syncytium formation | 3.01e-06 | 89 | 276 | 9 | GO:0006949 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | EPHB6 MYO9A CDHR1 SIPA1L3 LGR4 VSIG1 LARP4 WLS TENM2 PICALM B4GALT5 MAPK8IP3 DIP2A PTPRJ NECTIN1 PKHD1 KIF13B FLNB WNT5A FAT3 SMURF1 APBB2 GSK3B SYNE3 EFNB2 NSMF CSF1R UNC5C SLIT3 EIF4G2 DOCK7 LRP2 PRKG1 ZMYM4 ZMYM3 CUX1 | 4.38e-06 | 1194 | 276 | 36 | GO:0000902 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | EPHB6 CDHR1 LGR4 WLS TENM2 PICALM B4GALT5 MAPK8IP3 DIP2A NECTIN1 KIF13B WNT5A FAT3 SMURF1 APBB2 GSK3B EFNB2 NSMF CSF1R UNC5C SLIT3 EIF4G2 DOCK7 LRP2 PRKG1 CUX1 | 9.37e-06 | 748 | 276 | 26 | GO:0048667 |
| GeneOntologyBiologicalProcess | DNA integration | 2.04e-05 | 13 | 276 | 4 | GO:0015074 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | CDHR1 NECTIN1 DSC1 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA5 PCDHGA1 FAT3 PCDHA13 PCDH9 | 4.59e-05 | 187 | 276 | 11 | GO:0007156 |
| GeneOntologyBiologicalProcess | axon development | EPHB6 LGR4 TENM2 PICALM B4GALT5 MAPK8IP3 NECTIN1 BORCS7 KIF13B WNT5A SMURF1 APBB2 INPP5F GSK3B EFNB2 CSF1R UNC5C SLIT3 EIF4G2 DOCK7 LRP2 PRKG1 | 5.75e-05 | 642 | 276 | 22 | GO:0061564 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | EPHB6 MYO9A LGR4 WLS TENM2 PICALM B4GALT5 MAPK8IP3 DIP2A NECTIN1 KIF13B WNT5A SMURF1 APBB2 GSK3B EFNB2 NSMF CSF1R UNC5C SLIT3 EIF4G2 DOCK7 LRP2 PRKG1 CUX1 | 8.28e-05 | 802 | 276 | 25 | GO:0048812 |
| GeneOntologyBiologicalProcess | axonogenesis | EPHB6 LGR4 TENM2 PICALM B4GALT5 MAPK8IP3 NECTIN1 KIF13B WNT5A SMURF1 APBB2 GSK3B EFNB2 CSF1R UNC5C SLIT3 EIF4G2 DOCK7 LRP2 PRKG1 | 8.29e-05 | 566 | 276 | 20 | GO:0007409 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | CDHR1 ACVR1 TENM2 NECTIN1 DSC1 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA5 PCDHGA1 FAT3 PCDHA13 TENM4 PCDH9 | 8.93e-05 | 313 | 276 | 14 | GO:0098742 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | EPHB6 MYO9A LGR4 WLS TENM2 PICALM B4GALT5 MAPK8IP3 DIP2A NECTIN1 KIF13B WNT5A SMURF1 APBB2 GSK3B EFNB2 NSMF CSF1R UNC5C SLIT3 EIF4G2 DOCK7 LRP2 PRKG1 CUX1 | 1.15e-04 | 819 | 276 | 25 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | EPHB6 MYO9A LGR4 WLS TENM2 PICALM B4GALT5 MAPK8IP3 DIP2A NECTIN1 KIF13B WNT5A SMURF1 APBB2 GSK3B EFNB2 NSMF CSF1R UNC5C SLIT3 EIF4G2 DOCK7 LRP2 PRKG1 CUX1 | 1.31e-04 | 826 | 276 | 25 | GO:0048858 |
| GeneOntologyCellularComponent | axon | ZC3H14 MYO9A TENM2 STAT1 MAPK8IP3 ITPR2 SACS KCNH1 NECTIN1 C4A C4B LRRC7 USH2A NOS1 KIF13B CACNA1C RAPGEF4 SMURF1 APBB2 INPP5F GSK3B AP3B2 UNC5C EIF4G2 DOCK7 LRP2 RIMBP2 PCDH9 | 2.09e-05 | 891 | 276 | 28 | GO:0030424 |
| GeneOntologyCellularComponent | dendrite | EPHB6 ZC3H14 WLS TENM2 STAT1 MAPK8IP3 DIP2A SACS KCNH1 NECTIN1 C4A C4B LRRC7 NOS1 CACNA1C FAT3 RAPGEF4 CPE INPP5F GSK3B PPP1CA EFNB2 NSMF UNC5C LRP2 GABRA6 | 7.60e-05 | 858 | 276 | 26 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | EPHB6 ZC3H14 WLS TENM2 STAT1 MAPK8IP3 DIP2A SACS KCNH1 NECTIN1 C4A C4B LRRC7 NOS1 CACNA1C FAT3 RAPGEF4 CPE INPP5F GSK3B PPP1CA EFNB2 NSMF UNC5C LRP2 GABRA6 | 7.89e-05 | 860 | 276 | 26 | GO:0097447 |
| GeneOntologyCellularComponent | somatodendritic compartment | EPHB6 ZC3H14 WLS TENM2 PICALM STAT1 MAPK8IP3 DIP2A SACS KCNH1 NECTIN1 C4A C4B LRRC7 USH2A NOS1 CACNA1C FLNB FAT3 RAPGEF4 SMURF1 CPE INPP5F GSK3B PPP1CA EFNB2 NSMF CSF1R G3BP1 LNPEP UNC5C LRP2 GABRA6 | 8.47e-05 | 1228 | 276 | 33 | GO:0036477 |
| GeneOntologyCellularComponent | growth cone | MYO9A TENM2 MAPK8IP3 NECTIN1 RAPGEF4 APBB2 GSK3B UNC5C DOCK7 LRP2 PCDH9 | 4.37e-04 | 245 | 276 | 11 | GO:0030426 |
| GeneOntologyCellularComponent | glycerol-3-phosphate dehydrogenase (FAD) complex | 5.17e-04 | 3 | 276 | 2 | GO:0009331 | |
| GeneOntologyCellularComponent | site of polarized growth | MYO9A TENM2 MAPK8IP3 NECTIN1 RAPGEF4 APBB2 GSK3B UNC5C DOCK7 LRP2 PCDH9 | 5.71e-04 | 253 | 276 | 11 | GO:0030427 |
| GeneOntologyCellularComponent | clathrin-coated pit | 6.66e-04 | 80 | 276 | 6 | GO:0005905 | |
| HumanPheno | Abnormal nasal tip morphology | KDM3B PHF8 SRCAP KCNH1 AGL MIPEP MYO18B DOCK6 FLNB FRAS1 BICRA POR TBL1XR1 KMT2D NSMF CSF1R SETD5 AIFM1 MED25 DOCK7 LRP2 MBD5 CUX1 | 6.45e-07 | 386 | 98 | 23 | HP:0000436 |
| Domain | Cadherin_CS | CDHR1 DSC1 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA5 PCDHGA1 FAT3 PCDHA13 PCDH9 | 3.71e-06 | 109 | 267 | 10 | IPR020894 |
| Domain | CADHERIN_1 | CDHR1 DSC1 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA5 PCDHGA1 FAT3 PCDHA13 PCDH9 | 5.13e-06 | 113 | 267 | 10 | PS00232 |
| Domain | Cadherin | CDHR1 DSC1 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA5 PCDHGA1 FAT3 PCDHA13 PCDH9 | 5.13e-06 | 113 | 267 | 10 | PF00028 |
| Domain | - | CDHR1 DSC1 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA5 PCDHGA1 FAT3 PCDHA13 PCDH9 | 5.56e-06 | 114 | 267 | 10 | 2.60.40.60 |
| Domain | CADHERIN_2 | CDHR1 DSC1 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA5 PCDHGA1 FAT3 PCDHA13 PCDH9 | 5.56e-06 | 114 | 267 | 10 | PS50268 |
| Domain | CA | CDHR1 DSC1 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA5 PCDHGA1 FAT3 PCDHA13 PCDH9 | 6.01e-06 | 115 | 267 | 10 | SM00112 |
| Domain | Cadherin-like | CDHR1 DSC1 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA5 PCDHGA1 FAT3 PCDHA13 PCDH9 | 6.50e-06 | 116 | 267 | 10 | IPR015919 |
| Domain | Cadherin | CDHR1 DSC1 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA5 PCDHGA1 FAT3 PCDHA13 PCDH9 | 7.57e-06 | 118 | 267 | 10 | IPR002126 |
| Domain | Cadherin_tail | 1.29e-05 | 37 | 267 | 6 | PF15974 | |
| Domain | Cadherin_CBD | 1.29e-05 | 37 | 267 | 6 | IPR031904 | |
| Domain | ABC_A | 1.85e-05 | 12 | 267 | 4 | IPR026082 | |
| Domain | Cadherin_2 | 3.87e-05 | 65 | 267 | 7 | PF08266 | |
| Domain | Cadherin_N | 3.87e-05 | 65 | 267 | 7 | IPR013164 | |
| Domain | CNMP_BINDING_1 | 8.44e-05 | 32 | 267 | 5 | PS00888 | |
| Domain | CNMP_BINDING_2 | 8.44e-05 | 32 | 267 | 5 | PS00889 | |
| Domain | cNMP | 1.14e-04 | 34 | 267 | 5 | SM00100 | |
| Domain | cNMP_binding | 1.14e-04 | 34 | 267 | 5 | PF00027 | |
| Domain | cNMP-bd_dom | 1.31e-04 | 35 | 267 | 5 | IPR000595 | |
| Domain | CNMP_BINDING_3 | 1.31e-04 | 35 | 267 | 5 | PS50042 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 1.53e-04 | 8 | 267 | 3 | IPR019565 | |
| Domain | Thiol-ester_cl | 1.53e-04 | 8 | 267 | 3 | PF10569 | |
| Domain | MacrogloblnA2_CS | 1.53e-04 | 8 | 267 | 3 | IPR019742 | |
| Domain | cNMP-bd-like | 1.96e-04 | 38 | 267 | 5 | IPR018490 | |
| Domain | cGMP_dep_kinase | 2.04e-04 | 2 | 267 | 2 | IPR002374 | |
| Domain | ASH | 2.04e-04 | 2 | 267 | 2 | PF15780 | |
| Domain | DUF3480 | 2.04e-04 | 2 | 267 | 2 | PF11979 | |
| Domain | DUF3480 | 2.04e-04 | 2 | 267 | 2 | IPR022557 | |
| Domain | Znf_FYVE_endofin | 2.04e-04 | 2 | 267 | 2 | IPR017165 | |
| Domain | ASH | 2.04e-04 | 2 | 267 | 2 | IPR031549 | |
| Domain | Cadherin_C | 3.17e-04 | 42 | 267 | 5 | IPR032455 | |
| Domain | Cadherin_C_2 | 3.17e-04 | 42 | 267 | 5 | PF16492 | |
| Domain | A2M | 3.22e-04 | 10 | 267 | 3 | PF00207 | |
| Domain | A2M_N_2 | 3.22e-04 | 10 | 267 | 3 | IPR011625 | |
| Domain | A2M_comp | 3.22e-04 | 10 | 267 | 3 | IPR011626 | |
| Domain | A2M_recep | 3.22e-04 | 10 | 267 | 3 | PF07677 | |
| Domain | A2M_comp | 3.22e-04 | 10 | 267 | 3 | PF07678 | |
| Domain | A2M_N_2 | 3.22e-04 | 10 | 267 | 3 | PF07703 | |
| Domain | A2M_N | 3.22e-04 | 10 | 267 | 3 | PF01835 | |
| Domain | A2M_N | 3.22e-04 | 10 | 267 | 3 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 3.22e-04 | 10 | 267 | 3 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 3.22e-04 | 10 | 267 | 3 | PS00477 | |
| Domain | Macroglobln_a2 | 3.22e-04 | 10 | 267 | 3 | IPR001599 | |
| Domain | Ephrin_rec_like | 4.38e-04 | 11 | 267 | 3 | PF07699 | |
| Domain | EGF | HYAL4 TENM2 SVEP1 FCGBP ATRAID FRAS1 FAT3 CUBN TENM4 SLIT3 LRP2 | 5.91e-04 | 235 | 267 | 11 | SM00181 |
| Domain | ABC_TRANSPORTER_2 | 5.96e-04 | 48 | 267 | 5 | PS50893 | |
| Domain | ABC_tran | 5.96e-04 | 48 | 267 | 5 | PF00005 | |
| Domain | - | 5.96e-04 | 48 | 267 | 5 | 2.60.120.10 | |
| Domain | FN3 | EPHB6 OBSCN PTPRJ RIMBP3C USH2A RIMBP3 IFNGR2 POMGNT2 RIMBP2 RIMBP3B | 6.04e-04 | 199 | 267 | 10 | PS50853 |
| Domain | Rhs_assc_core | 6.05e-04 | 3 | 267 | 2 | IPR022385 | |
| Domain | Transcrpt_fac_DP | 6.05e-04 | 3 | 267 | 2 | IPR015648 | |
| Domain | DP | 6.05e-04 | 3 | 267 | 2 | PF08781 | |
| Domain | L_AA_transporter | 6.05e-04 | 3 | 267 | 2 | IPR004760 | |
| Domain | Transc_factor_DP_C | 6.05e-04 | 3 | 267 | 2 | IPR014889 | |
| Domain | DP | 6.05e-04 | 3 | 267 | 2 | SM01138 | |
| Domain | ABC_TRANSPORTER_1 | 6.56e-04 | 49 | 267 | 5 | PS00211 | |
| Domain | ABC_transporter-like | 7.21e-04 | 50 | 267 | 5 | IPR003439 | |
| Domain | NHL | 7.43e-04 | 13 | 267 | 3 | PS51125 | |
| Domain | RmlC-like_jellyroll | 7.90e-04 | 51 | 267 | 5 | IPR014710 | |
| Domain | FN3_dom | EPHB6 OBSCN PTPRJ RIMBP3C USH2A RIMBP3 IFNGR2 POMGNT2 RIMBP2 RIMBP3B | 8.81e-04 | 209 | 267 | 10 | IPR003961 |
| Domain | - | 1.20e-03 | 4 | 267 | 2 | 3.90.1460.10 | |
| Domain | Tox-GHH_dom | 1.20e-03 | 4 | 267 | 2 | IPR028916 | |
| Domain | Tox-GHH | 1.20e-03 | 4 | 267 | 2 | PF15636 | |
| Domain | Ten_N | 1.20e-03 | 4 | 267 | 2 | PF06484 | |
| Domain | GTF2I | 1.20e-03 | 4 | 267 | 2 | PF02946 | |
| Domain | TENEURIN_N | 1.20e-03 | 4 | 267 | 2 | PS51361 | |
| Domain | Ten_N | 1.20e-03 | 4 | 267 | 2 | IPR009471 | |
| Domain | GTF2I | 1.20e-03 | 4 | 267 | 2 | PS51139 | |
| Domain | GTF2I | 1.20e-03 | 4 | 267 | 2 | IPR004212 | |
| Domain | CarboxyPept-like_regulatory | 1.69e-03 | 17 | 267 | 3 | IPR008969 | |
| Domain | Anaphylatoxn_comp_syst_dom | 1.98e-03 | 5 | 267 | 2 | IPR001840 | |
| Domain | DUF3504 | 1.98e-03 | 5 | 267 | 2 | IPR021893 | |
| Domain | DMAP_binding | 1.98e-03 | 5 | 267 | 2 | PF06464 | |
| Domain | Anaphylatoxin_comp_syst | 1.98e-03 | 5 | 267 | 2 | IPR018081 | |
| Domain | YD | 1.98e-03 | 5 | 267 | 2 | IPR006530 | |
| Domain | DUF3504 | 1.98e-03 | 5 | 267 | 2 | PF12012 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 2.01e-03 | 18 | 267 | 3 | IPR008930 | |
| Domain | - | 2.27e-03 | 39 | 267 | 4 | 2.120.10.30 | |
| Pathway | PID_BMP_PATHWAY | 2.38e-05 | 42 | 197 | 6 | M181 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 5.03e-05 | 94 | 197 | 8 | M1041 | |
| Pubmed | PDXDC1 ZC3H14 ZFYVE16 PDLIM7 TBC1D5 ECHDC1 SIPA1L3 LARP4 WLS PICALM C2CD5 NUP54 TMX1 POGLUT1 MAP7D2 MIA3 MACROH2A1 INPP5F PRC1 CCNA2 RALY ARFGAP2 PDIA6 RBM12 EFNB2 G3BP1 EIF4G2 RACGAP1 TMPO TMEM131 R3HDM1 ZMYM4 | 4.82e-11 | 1007 | 280 | 32 | 34597346 | |
| Pubmed | ZFYVE16 PDLIM7 TBC1D5 SIPA1L3 PHF8 BIRC6 ITPR2 NUDT12 ZFYVE9 PTPRJ GNL2 DEK GPD2 PSAT1 MIA3 PPM1E RALGAPB POR CEP192 GSK3B PPM1A PPP1CA PDIA6 KMT2D PPP2R5B AIFM1 LNPEP TMPO CSPP1 CNOT1 PTPN20 | 5.77e-10 | 1049 | 280 | 31 | 27880917 | |
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 4.11e-09 | 4 | 280 | 4 | 10469592 | |
| Pubmed | AFTPH MRPS27 DNAJC22 C2CD5 ITPR2 LRRC47 TMX1 DIP2A SACS ASPM GNL2 MAP7D2 SUCO DEK PNP FRAS1 MIA3 RALGAPB POR MACROH2A1 CEP192 TFDP1 TBC1D17 RALY PDIA6 SYNE3 EFNB2 AIFM1 LNPEP EIF4G2 TMPO SLC7A5 TMEM131 ESPL1 CSPP1 CUX1 | 4.50e-09 | 1487 | 280 | 36 | 33957083 | |
| Pubmed | DENND4A PDLIM7 TBC1D5 SIPA1L3 BIRC6 C2CD5 MTCL1 DOCK6 MIA3 SH3RF1 RALGAPB CEP192 INPP5F PPP1CA DOCK7 TRAPPC14 R3HDM1 CSPP1 CNOT1 | 4.96e-09 | 446 | 280 | 19 | 24255178 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | DENND4A HIVEP1 MRPS27 STAT1 LRRC47 TMX1 GNL2 SGO2 MYO18B DEK HNRNPLL SEC23A GPD2 FLNB PSAT1 DSC1 POR ABCF2 MACROH2A1 TMEM43 PRC1 YARS1 PPP1CA RALY GBA3 GSTP1 PDIA6 G3BP1 AIFM1 EIF4G2 DOCK7 RACGAP1 TMPO SLC7A5 CNOT1 | 5.24e-09 | 1425 | 280 | 35 | 30948266 |
| Pubmed | DENND4A SIPA1L3 COQ3 SRCAP NUP54 BRCA1 SACS ASPM GTF2IRD2 PKHD1 MAP7D2 SMURF2 ERICH6 BAHCC1 KIF13B CACNA1C FLNB PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA5 PCDHGA1 RALYL ABCF2 MACROH2A1 TMEM43 PPP1CA RALY GTF2IRD2B PDIA6 SETD5 UNC5C TMPO SLC7A5 CUX1 | 7.07e-09 | 1442 | 280 | 35 | 35575683 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PDE4A SIPA1L3 OBSCN KDM3B SRCAP BIRC6 MAPK8IP3 ITPR2 DIP2A DOCK6 SMURF2 BAHCC1 FRAS1 SH3RF1 RASA3 CTC1 BICRA CEP192 LARS2 TBC1D17 KMT2D SYNE3 POMGNT2 SETD5 TTLL4 HPS6 DIP2C SLC7A5 MBD5 ESPL1 | 7.76e-09 | 1105 | 280 | 30 | 35748872 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DYM MYO9A TBC1D5 SIPA1L3 OBSCN LARP4 GALNT18 MAPK8IP3 POGLUT1 PTPRJ LRRC7 DOCK6 SMURF2 CACNA1C FLNB PSAT1 MIA3 RASA3 BICRA RALGAPB EXOSC3 SMURF1 APBB2 MACROH2A1 CEP192 TBL1XR1 RALY EFNB2 SETD5 DIP2C CSMD1 MBD5 CNOT1 ZMYM4 CUX1 | 1.58e-08 | 1489 | 280 | 35 | 28611215 |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 2.04e-08 | 5 | 280 | 4 | 12629516 | |
| Pubmed | Structure and evolution of RIM-BP genes: identification of a novel family member. | 2.04e-08 | 5 | 280 | 4 | 17855024 | |
| Pubmed | 2.47e-08 | 12 | 280 | 5 | 14557543 | ||
| Pubmed | PDXDC1 DENND4A ZFYVE16 TBC1D5 CHML ITPR2 TMX1 ZFYVE9 OSBPL11 DOCK6 SEC23A GPD2 APBB2 POR TMEM43 LNPEP LRP2 TMPO TMEM131 | 3.49e-08 | 504 | 280 | 19 | 34432599 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DENND4A HIVEP1 AFTPH MYO9A TBC1D5 SIPA1L3 KDM3B MTCL1 DOCK6 KIF13B SH3RF1 RALGAPB CEP192 PLEKHG2 INPP5F PPM1A PPP1CA ARFGAP2 DCP1B SAMD11 DOCK7 RACGAP1 TRAPPC14 R3HDM1 CSPP1 | 4.12e-08 | 861 | 280 | 25 | 36931259 |
| Pubmed | ZFYVE16 PHF8 TENM2 LRRC7 MTCL1 IQSEC3 FRAS1 PPM1E RALGAPB SMURF1 CEP192 TENM4 SETD5 DOCK7 RIMBP2 R3HDM1 ZMYM3 | 4.32e-08 | 407 | 280 | 17 | 12693553 | |
| Pubmed | MYO9A SIPA1L3 MAPK8IP3 ITPR2 LRRC47 DIP2A CLCN6 SACS MAP7D2 C4A C4B LRRC7 NOS1 SEC23A GPD2 FLNB IQSEC3 RAPGEF4 SMURF1 POR GSK3B YARS1 PPP1CA GSTP1 PDIA6 TENM4 G3BP1 AP3B2 EIF4G2 DOCK7 TMPO RIMBP2 CNOT1 | 6.58e-08 | 1431 | 280 | 33 | 37142655 | |
| Pubmed | ZFYVE16 SIPA1L3 PICALM ZFYVE9 GNL2 MTCL1 DOCK6 CEP192 LNPEP DOCK7 | 7.66e-08 | 125 | 280 | 10 | 29467281 | |
| Pubmed | DENND4A AFTPH ZFYVE16 PDLIM7 TBC1D5 PICALM ZFYVE9 APBB2 LNPEP AP3B2 UNC5C TMPO SLC7A5 TRAPPC14 | 9.62e-08 | 285 | 280 | 14 | 34369648 | |
| Pubmed | PDXDC1 AFTPH ZFYVE16 TBC1D5 CHML PICALM PTPRJ OSBPL11 PNP APBB2 APEX1 INPP5F LNPEP TMPO SLC7A5 | 1.30e-07 | 339 | 280 | 15 | 37232246 | |
| Pubmed | DENND4A AFTPH MYO9A SIPA1L3 PICALM MTCL1 MIA3 CEP192 GSK3B PPP1CA DCP1B DOCK7 | 1.51e-07 | 209 | 280 | 12 | 36779422 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | TOPAZ1 OBSCN PHF8 CHML BIRC6 ITPR2 LRRC47 NUDT12 DIP2A AGL PKHD1 LRRC7 MTCL1 FLNB MXRA5 EXOSC3 PARP14 PPM1A AIFM1 LRP2 TMPO CNOT1 | 1.69e-07 | 736 | 280 | 22 | 29676528 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MYO9A PDLIM7 PHF8 SRCAP SUCLG2 LARP4 BIRC6 STAT1 LRRC47 A2ML1 ASPM TP53RK SEC23A PNP FLNB DSC1 RASA3 EXOSC3 ABCF2 DGKD MACROH2A1 GSK3B PPP1CA RALY GSTP1 PDIA6 G3BP1 AIFM1 EIF4G2 RACGAP1 ZMYM3 | 1.96e-07 | 1353 | 280 | 31 | 29467282 |
| Pubmed | HIVEP1 MRPS27 PHF8 SRCAP LARP4 STAT1 NUP54 BRCA1 NFRKB GNL2 TAF12 MED10 BICRA CEP192 TBL1XR1 TFDP1 TFDP2 CCNA2 PPP1CA KMT2D RBM12 G3BP1 DCP1B AIFM1 SAMD11 LRP2 RACGAP1 R3HDM1 CNOT1 ZMYM4 ZMYM3 CUX1 | 2.04e-07 | 1429 | 280 | 32 | 35140242 | |
| Pubmed | PDXDC1 EDF1 PDLIM7 TBC1D5 NHLRC2 CHML WLS STAT1 TMX1 OSBPL11 FLNB MIA3 POR ARFGAP2 EIF4G2 TMPO SLC7A5 TMEM131 CUX1 | 2.22e-07 | 568 | 280 | 19 | 37774976 | |
| Pubmed | OBSCN LGR4 SRCAP WLS STAT1 C2CD5 KCNH1 NFRKB OSBPL11 SUCO KIF13B FLNB MIA3 CTC1 SMURF1 CEP192 CUBN SPATA1 SETD5 CSNK1G3 TTLL4 UNC5C EIF4G2 LRP2 TMEM131 ESPL1 CNOT1 | 2.53e-07 | 1084 | 280 | 27 | 11544199 | |
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | EPHB6 ABCA1 MYO9A TOPAZ1 DIP2A DYRK3 EXOSC3 MUC16 APEX1 PPM1A PPP1CA CSF1R G3BP1 EIF4G2 PTPN20 ZMYM4 | 3.74e-07 | 420 | 280 | 16 | 28065597 |
| Pubmed | DENND4A TBC1D5 KDM3B WLS LPIN1 PHKA2 DIP2A OSBPL11 C4A C4B COL6A2 RALGDS FRAS1 MIA3 RALGAPB TBC1D17 ARFGAP2 PDIA6 DOCK7 RACGAP1 | 3.98e-07 | 650 | 280 | 20 | 38777146 | |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | DYM ERN1 SIPA1L3 LGR4 ACVR1 SUCLG2 B4GALT5 OSBPL11 REV1 RALGDS DGKD TFDP2 PPM1A TENM4 G3BP1 TTLL4 MBD5 CUX1 | 4.40e-07 | 536 | 280 | 18 | 15840001 |
| Pubmed | DYM ERN1 SIPA1L3 LGR4 ACVR1 SUCLG2 B4GALT5 OSBPL11 REV1 RALGDS DGKD TFDP2 PPM1A TENM4 G3BP1 TTLL4 MBD5 CUX1 | 4.65e-07 | 538 | 280 | 18 | 10512203 | |
| Pubmed | MRPS27 BIRC6 TENM2 MAPK8IP3 TMX1 NECTIN1 MAP7D2 LRRC7 NOS1 HNRNPLL FLNB IQSEC3 MIA3 POR MACROH2A1 TMEM43 YARS1 PPP1CA RALY ARFGAP2 TENM4 POMGNT2 G3BP1 EIF4G2 DOCK7 SLC7A5 CNOT1 | 6.61e-07 | 1139 | 280 | 27 | 36417873 | |
| Pubmed | EDF1 DYM MRPS27 SUCLG2 PICALM ITPR2 LRRC47 GNL2 DEK GPD2 FLNB PSAT1 DDX60 EXOSC3 ABCF2 TMEM43 CCNA2 PPP1CA RALY GSTP1 PDIA6 G3BP1 AIFM1 EIF4G2 DOCK7 RACGAP1 TMPO SLC7A5 TRAPPC14 CNOT1 CUX1 | 7.40e-07 | 1440 | 280 | 31 | 30833792 | |
| Pubmed | PDXDC1 ZFYVE16 KDM3B LGR4 LARP4 BIRC6 STAT1 TMX1 POGLUT1 MTCL1 DEK PNP FLNB MIA3 EXOSC3 APEX1 TMEM43 LARS2 PAPSS1 GSK3B YARS1 PPP1CA GSTP1 PDIA6 G3BP1 AIFM1 LNPEP RACGAP1 CNOT1 | 8.14e-07 | 1297 | 280 | 29 | 33545068 | |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 9.77e-07 | 94 | 280 | 8 | 21542922 | |
| Pubmed | ZC3H14 EDF1 HIVEP1 KDM3B STAT1 BRCA1 NFRKB DEK HNRNPLL PNP MED10 BICRA APEX1 PRC1 TBL1XR1 GSK3B GSTP1 KMT2D RBM12 G3BP1 EIF4G2 TMPO CNOT1 ZMYM4 ZMYM3 CUX1 | 1.19e-06 | 1103 | 280 | 26 | 34189442 | |
| Pubmed | PDE4A TBC1D5 SIPA1L3 TENM2 PICALM MAPK8IP3 LRRC7 MTCL1 NOS1 SEC23A KIF13B IQSEC3 MIA3 RAPGEF4 MACROH2A1 TBL1XR1 GSK3B PPP1CA G3BP1 DOCK7 RACGAP1 RIMBP2 CNOT1 CUX1 | 1.20e-06 | 963 | 280 | 24 | 28671696 | |
| Pubmed | ZFYVE16 PDLIM7 PICALM LRRC7 MIA3 SH3RF1 WNT5A PDIA6 G3BP1 TMEM131 R3HDM1 CNOT1 | 1.73e-06 | 263 | 280 | 12 | 34702444 | |
| Pubmed | SUCLG2 BIRC6 LRRC47 TMX1 AGL FLNB PSAT1 ABCF2 LARS2 PAPSS1 YARS1 G3BP1 AIFM1 EIF4G2 DOCK7 TMPO CNOT1 | 1.91e-06 | 534 | 280 | 17 | 35032548 | |
| Pubmed | Macrophage-derived complement component C4 can restore humoral immunity in C4-deficient mice. | 2.05e-06 | 4 | 280 | 3 | 12421924 | |
| Pubmed | RIM-BP3 is a manchette-associated protein essential for spermiogenesis. | 2.05e-06 | 4 | 280 | 3 | 19091768 | |
| Pubmed | 2.05e-06 | 4 | 280 | 3 | 7983737 | ||
| Pubmed | VIP blockade leads to microcephaly in mice via disruption of Mcph1-Chk1 signaling. | 2.28e-06 | 27 | 280 | 5 | 21737879 | |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | 2.31e-06 | 74 | 280 | 7 | 10817752 | |
| Pubmed | ZFYVE16 KDM3B NHLRC2 LARP4 WLS BIRC6 ITPR2 TMX1 NUDT12 NFRKB GNL2 MIA3 RALY DCP1B TTLL4 RACGAP1 SLC7A5 TMEM131 R3HDM1 ESPL1 | 2.51e-06 | 733 | 280 | 20 | 34672954 | |
| Pubmed | 3.02e-06 | 77 | 280 | 7 | 10835267 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | TOPAZ1 OBSCN MRPS27 DIP2A GNL2 C4A C4B ADGRF3 CACNA1C RAPGEF4 MACROH2A1 PPP1CA TMPO CSPP1 CNOT1 HYDIN | 3.33e-06 | 497 | 280 | 16 | 36774506 |
| Pubmed | DENND4A HIVEP1 OBSCN SUCLG2 BIRC6 AGL FBXO32 TP53RK MYO18B GPD1 FLNB ABCF2 DGKD GSTP1 EIF4G2 ZMYM4 | 3.33e-06 | 497 | 280 | 16 | 23414517 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | ZC3H14 PDLIM7 SRCAP STAT1 NUP54 ITPR2 SACS GNL2 DEK SEC23A GPD2 FLNB ABCF2 MACROH2A1 PPP1CA RALY GSTP1 PDIA6 G3BP1 AIFM1 DOCK7 RACGAP1 TMPO CNOT1 | 3.44e-06 | 1024 | 280 | 24 | 24711643 |
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | 3.91e-06 | 80 | 280 | 7 | 10716726 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | ZC3H14 MRPS27 PHF8 LARP4 BIRC6 ASPM GNL2 SGO2 DEK EXOSC3 ABCF2 MACROH2A1 PRC1 RALY G3BP1 AIFM1 RACGAP1 TMPO ESPL1 CNOT1 | 4.22e-06 | 759 | 280 | 20 | 35915203 |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | AFTPH PDLIM7 TBC1D5 KDM3B PICALM STAT1 LPIN1 ARL14EP TAF12 DOCK6 DEK SEC23A TBL1XR1 GSK3B TBC1D17 ARFGAP2 DCP1B TTLL4 HPS6 EIF4G2 DOCK7 R3HDM1 ESPL1 CNOT1 | 4.33e-06 | 1038 | 280 | 24 | 26673895 |
| Pubmed | PDXDC1 ZFYVE16 PDLIM7 WLS PICALM TMX1 OSBPL11 DEK PPP1CA ARFGAP2 LNPEP EIF4G2 DOCK7 TMPO SLC7A5 | 4.34e-06 | 449 | 280 | 15 | 31732153 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | PDXDC1 MRPS27 SUCLG2 CHML LARP4 BIRC6 ITPR2 TMX1 DIP2A MIPEP GNL2 OSBPL11 SUCO SEC23A GPD2 MIA3 POR MACROH2A1 LARS2 GSK3B YARS1 TBC1D17 RALY AIFM1 LRP2 TMPO TMEM131 R3HDM1 ESPL1 CUX1 | 4.67e-06 | 1496 | 280 | 30 | 32877691 |
| Pubmed | Evolutionary analysis of a cluster of ATP-binding cassette (ABC) genes. | 5.10e-06 | 5 | 280 | 3 | 12532264 | |
| Pubmed | 5.10e-06 | 5 | 280 | 3 | 28798345 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | HIVEP1 AFTPH KDM3B PHF8 C2CD5 MAPK8IP3 TMX1 NFRKB OSBPL11 RALGAPB GSK3B PDIA6 KMT2D G3BP1 EIF4G2 TMPO SLC7A5 ESPL1 ZMYM4 ZMYM3 | 5.63e-06 | 774 | 280 | 20 | 15302935 |
| Pubmed | PDXDC1 KDM3B LGR4 BIRC6 BRCA1 HNRNPLL SEC23A APBB2 POR MUC16 CEP192 GSTP1 ARFGAP2 EFNB2 UNC5C DOCK7 TMPO SLC7A5 PCDH9 CUX1 | 5.96e-06 | 777 | 280 | 20 | 35844135 | |
| Pubmed | 6.93e-06 | 16 | 280 | 4 | 29764992 | ||
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | ZC3H14 MRPS27 PICALM INTS15 GNL2 FRAS1 PARP14 CCNA2 ARFGAP2 KMT2D G3BP1 DOCK7 RACGAP1 ZMYM4 | 7.08e-06 | 410 | 280 | 14 | 26949251 |
| Pubmed | HIVEP1 ZFYVE16 PDLIM7 KDM3B SVEP1 ZNF587B ZNF518A PHKA2 ZFYVE9 SMURF2 FLNB SMURF1 PPP1CA KMT2D DCP1B LNPEP EIF4G2 | 7.29e-06 | 591 | 280 | 17 | 15231748 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | HIVEP1 KDM3B SUCLG2 LRRC47 BRCA1 NFRKB GNL2 OSBPL11 MTCL1 KIF13B FLNB DSC1 ADAMTS1 CEP192 CCNA2 RALY G3BP1 DCP1B EIF4G2 DOCK7 RIMBP2 CNOT1 ZMYM4 | 8.13e-06 | 1005 | 280 | 23 | 19615732 |
| Pubmed | HIVEP1 ZFYVE16 BIRC6 ARL14EP FLNB INPP5F TFDP1 KMT2D DOCK7 LRP2 CNOT1 ZMYM4 ZMYM3 CUX1 | 8.81e-06 | 418 | 280 | 14 | 34709266 | |
| Pubmed | 1.01e-05 | 6 | 280 | 3 | 15063128 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | HIVEP1 KDM3B PHF8 SRCAP BRCA1 NFRKB GNL2 SGO2 DEK APEX1 TBL1XR1 TFDP1 RACGAP1 TMPO ZMYM4 ZMYM3 CUX1 | 1.05e-05 | 608 | 280 | 17 | 36089195 |
| Pubmed | 1.15e-05 | 18 | 280 | 4 | 18664271 | ||
| Pubmed | 1.17e-05 | 131 | 280 | 8 | 34551306 | ||
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | PDXDC1 WLS SLC7A11 PICALM C2CD5 DIP2A PTPRJ RASA3 CSNK1G3 DOCK7 TMPO SLC7A5 DCUN1D3 | 1.36e-05 | 377 | 280 | 13 | 38117590 |
| Pubmed | SIPA1L3 KDM3B PHF8 BIRC6 ZNF518A CLCN6 RALGAPB RBM12 TENM4 DIP2C | 1.60e-05 | 225 | 280 | 10 | 12168954 | |
| Pubmed | 1.60e-05 | 225 | 280 | 10 | 31478661 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | PDXDC1 ZFYVE16 PDLIM7 SIPA1L3 PICALM STAT1 PTPRJ NECTIN1 LRRC7 FLNB SH3RF1 MACROH2A1 PPP1CA ARFGAP2 EIF4G2 TMPO | 1.64e-05 | 565 | 280 | 16 | 25468996 |
| Pubmed | 1.76e-05 | 7 | 280 | 3 | 31553910 | ||
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | 1.86e-05 | 68 | 280 | 6 | 11230163 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | EDF1 PDLIM7 TBC1D5 KDM3B SUCLG2 STAT1 LRRC47 TMX1 FCGBP AGL A2ML1 TP53RK SEC23A GPD2 FLNB DSC1 APEX1 MACROH2A1 TBL1XR1 RALY ERG28 G3BP1 AIFM1 EIF4G2 TMPO SLC7A5 CNOT1 | 1.87e-05 | 1367 | 280 | 27 | 32687490 |
| Pubmed | OBSCN GNL2 DEK FLNB MACROH2A1 PPP1CA RALY G3BP1 DOCK7 TMPO CNOT1 ZMYM3 | 1.95e-05 | 334 | 280 | 12 | 30425250 | |
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | 2.58e-05 | 72 | 280 | 6 | 10380929 | |
| Pubmed | 2.68e-05 | 22 | 280 | 4 | 8894702 | ||
| Pubmed | Neurons under T Cell Attack Coordinate Phagocyte-Mediated Synaptic Stripping. | 2.81e-05 | 8 | 280 | 3 | 30173917 | |
| Pubmed | CK2 kinase-mediated PHF8 phosphorylation controls TopBP1 stability to regulate DNA replication. | 2.81e-05 | 8 | 280 | 3 | 33010150 | |
| Pubmed | PDXDC1 WLS SLC7A11 TMX1 NECTIN1 POR EFNB2 LNPEP CSNK1G3 TMPO SLC7A5 DCUN1D3 PCDH9 CUX1 | 3.00e-05 | 467 | 280 | 14 | 30194290 | |
| Pubmed | SIPA1L3 LARP4 PICALM STAT1 FLNB EXOSC3 ABCF2 PPP1CA RALY EIF4G2 TMPO | 3.08e-05 | 295 | 280 | 11 | 26209609 | |
| Pubmed | WLS BIRC6 ITPR2 LRRC47 LRRC7 ADAMTS1 MFSD11 PPP1CA DOCK7 TMPO SLC7A5 | 3.18e-05 | 296 | 280 | 11 | 34186245 | |
| Pubmed | LGR4 PHF8 SRCAP C2CD5 ZNF518A BRCA1 NFRKB ASPM GNL2 TAF12 BAHCC1 ADAMTS1 BICRA FAT3 RALYL MACROH2A1 TFDP1 TFDP2 RALY SETD5 LRP2 CSMD1 ZMYM3 | 4.18e-05 | 1116 | 280 | 23 | 31753913 | |
| Pubmed | 4.49e-05 | 116 | 280 | 7 | 30804394 | ||
| Pubmed | ZC3H14 PDLIM7 KDM3B PHF8 SRCAP STAT1 NFRKB OSBPL11 PPP1CA KMT2D DOCK7 TMPO CNOT1 ZMYM4 CUX1 | 4.53e-05 | 549 | 280 | 15 | 38280479 | |
| Pubmed | 4.55e-05 | 25 | 280 | 4 | 38877142 | ||
| Pubmed | Docking motif-guided mapping of the interactome of protein phosphatase-1. | 4.71e-05 | 80 | 280 | 6 | 19389623 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | PDXDC1 KDM3B NHLRC2 BIRC6 STAT1 LRRC47 AGL NFRKB OSBPL11 TP53RK DEK SEC23A PNP FLNB PSAT1 APEX1 ABCF2 PAPSS1 TBL1XR1 YARS1 TBC1D17 PPP1CA PDIA6 RBM12 G3BP1 LNPEP CNOT1 | 5.44e-05 | 1455 | 280 | 27 | 22863883 |
| Pubmed | 5.62e-05 | 210 | 280 | 9 | 16565220 | ||
| Pubmed | The human ATP-binding cassette (ABC) transporter superfamily. | 5.94e-05 | 10 | 280 | 3 | 11435397 | |
| Pubmed | 5.94e-05 | 10 | 280 | 3 | 12970426 | ||
| Pubmed | Circular rapid amplification of cDNA ends for high-throughput extension cloning of partial genes. | 6.20e-05 | 84 | 280 | 6 | 15203218 | |
| Pubmed | 6.46e-05 | 2 | 280 | 2 | 12244165 | ||
| Pubmed | 6.46e-05 | 2 | 280 | 2 | 19062096 | ||
| Pubmed | Antigen-induced B cell apoptosis is independent of complement C4. | 6.46e-05 | 2 | 280 | 2 | 17645767 | |
| Pubmed | Interaction of cCMP with the cGK, cAK and MAPK Kinases in Murine Tissues. | 6.46e-05 | 2 | 280 | 2 | 25978317 | |
| Pubmed | 6.46e-05 | 2 | 280 | 2 | 12207352 | ||
| Pubmed | Cloning and expression of a novel cyclic GMP-dependent protein kinase from mouse brain. | 6.46e-05 | 2 | 280 | 2 | 8514791 | |
| Pubmed | Impaired relaxation of stomach smooth muscle in mice lacking cyclic GMP-dependent protein kinase I. | 6.46e-05 | 2 | 280 | 2 | 10694248 | |
| Pubmed | Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients. | 6.46e-05 | 2 | 280 | 2 | 27758680 | |
| Pubmed | 6.46e-05 | 2 | 280 | 2 | 23978537 | ||
| Pubmed | Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein. | 6.46e-05 | 2 | 280 | 2 | 3037333 | |
| Interaction | RAB4A interactions | PDXDC1 DENND4A AFTPH ZFYVE16 TBC1D5 CHML WLS ZFYVE9 OSBPL11 PNP KIF13B MIA3 RALGAPB POR APEX1 INPP5F LNPEP LRP2 TMPO SLC7A5 | 4.16e-06 | 457 | 271 | 20 | int:RAB4A |
| Interaction | IFITM1 interactions | PDXDC1 ZFYVE16 PICALM TMX1 DIP2A ZFYVE9 PTPRJ OSBPL11 SEC23A BORCS7 ADAMTS1 APBB2 YARS1 LNPEP LRP2 RACGAP1 SLC7A5 | 6.93e-06 | 355 | 271 | 17 | int:IFITM1 |
| Interaction | B3GAT1 interactions | PDXDC1 ZFYVE16 PICALM STAT1 ITPR2 TMX1 ZFYVE9 OSBPL11 MIA3 APBB2 POR ARFGAP2 EFNB2 UNC5C TMPO SLC7A5 TMEM131 | 1.51e-05 | 377 | 271 | 17 | int:B3GAT1 |
| Interaction | FANCC interactions | 2.66e-05 | 89 | 271 | 8 | int:FANCC | |
| Interaction | GGH interactions | PDXDC1 NHLRC2 GALNT18 STAT1 POGLUT1 COL6A2 FRAS1 MIA3 TMEM43 POMGNT2 EIF4G2 TMEM131 ZMYM3 | 2.70e-05 | 243 | 271 | 13 | int:GGH |
| Interaction | PKHD1 interactions | 2.88e-05 | 14 | 271 | 4 | int:PKHD1 | |
| Cytoband | 5q31 | 7.11e-06 | 115 | 279 | 7 | 5q31 | |
| Cytoband | 12q13.12 | 8.37e-05 | 38 | 279 | 4 | 12q13.12 | |
| GeneFamily | ATP binding cassette subfamily A | 6.09e-06 | 14 | 164 | 4 | 805 | |
| GeneFamily | Clustered protocadherins | 2.47e-05 | 64 | 164 | 6 | 20 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 5.91e-05 | 9 | 164 | 3 | 1234 | |
| GeneFamily | Transcription factor Dp family | 2.44e-04 | 3 | 164 | 2 | 987 | |
| GeneFamily | Zinc fingers MYM-type | 1.20e-03 | 6 | 164 | 2 | 86 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.34e-03 | 181 | 164 | 7 | 694 | |
| Coexpression | GSE3920_UNTREATED_VS_IFNB_TREATED_ENDOTHELIAL_CELL_DN | TMX1 SGO2 FLNB BICRA DDX60 PRC1 LARS2 TFDP1 CCNA2 AIFM1 TMPO ZMYM3 | 2.96e-07 | 175 | 270 | 12 | M6694 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ZC3H14 HIVEP1 ZFYVE16 KDM3B ACVR1 PHF8 LARP4 PICALM C2CD5 ZFYVE9 BRCA1 SACS MTCL1 SUCO DEK SMURF2 FLNB WNT5A APBB2 INPP5F LARS2 GSK3B TMEM131 R3HDM1 ZMYM4 CUX1 | 9.86e-07 | 856 | 270 | 26 | M4500 |
| Coexpression | JOHNSTONE_PARVB_TARGETS_3_DN | ECHDC1 SLC7A11 NUP54 TMX1 SACS ASPM OSBPL11 SGO2 SUCO DEK HNRNPLL SMURF2 IQSEC3 PSAT1 PRC1 TFDP1 YARS1 PPM1A CCNA2 PDIA6 RBM12 RACGAP1 TMPO ZNF814 SLC7A5 CSPP1 | 1.54e-06 | 877 | 270 | 26 | M2241 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | HIVEP1 ACVR1 LARP4 PICALM C2CD5 ZFYVE9 BRCA1 MTCL1 SMURF2 FLNB WNT5A INPP5F LARS2 GSK3B TMEM131 R3HDM1 ZMYM4 CUX1 | 1.90e-06 | 466 | 270 | 18 | M13522 |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | GALNT18 PTPRJ PKHD1 FRAS1 RALYL CUBN TFDP2 LRP2 DIP2C MBD5 CSPP1 CUX1 | 3.48e-06 | 221 | 270 | 12 | M39222 |
| Coexpression | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP | HIVEP1 STAT1 POGLUT1 SGO2 HNRNPLL DDX60 PRC1 CCNA2 EFNB2 G3BP1 DOCK7 RACGAP1 TMPO | 1.87e-05 | 305 | 270 | 13 | M19875 |
| Coexpression | HALLMARK_TGF_BETA_SIGNALING | 1.93e-05 | 54 | 270 | 6 | M5896 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | CHML SLC7A11 B4GALT5 ASPM GNL2 SGO2 FBXO32 TP53RK PSAT1 RALGAPB SMURF1 TBL1XR1 GSK3B YARS1 LNPEP CSNK1G3 EIF4G2 RACGAP1 TMPO SLC7A5 CNOT1 | 2.11e-05 | 721 | 270 | 21 | M10237 |
| Coexpression | GSE36826_NORMAL_VS_STAPH_AUREUS_INF_IL1R_KO_SKIN_DN | PDE4A DYM PDLIM7 PICALM OSBPL11 POR PAPSS1 SYNE3 CSF1R TTLL4 | 4.41e-05 | 199 | 270 | 10 | M9532 |
| Coexpression | GSE40277_GATA1_AND_SATB1_TRANSDUCED_VS_CTRL_CD4_TCELL_DN | LARP4 SRSF12 NUDT12 RASA3 DDX60 DGKD EIF4G2 ZMYM4 ZMYM3 CUX1 | 4.41e-05 | 199 | 270 | 10 | M9178 |
| Coexpression | GSE5589_UNSTIM_VS_45MIN_LPS_AND_IL6_STIM_MACROPHAGE_DN | PDXDC1 LGR4 COQ3 WLS B4GALT5 INTS15 FBXO32 HNRNPLL ADAMTS1 DCUN1D3 | 4.60e-05 | 200 | 270 | 10 | M6607 |
| Coexpression | DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP | MYL4 KDM3B ZKSCAN7 ACVR1 PICALM NUP54 ITPR2 TMX1 POGLUT1 BRCA1 AGL BTK MIPEP GNL2 C4A DEK PNP ABCF2 PAPSS1 TFDP1 YARS1 TFDP2 PPM1A ARFGAP2 ERG28 G3BP1 AIFM1 CSNK1G3 EIF4G2 SLC7A5 QTRT1 | 5.23e-05 | 1399 | 270 | 31 | M535 |
| Coexpression | MOOTHA_GLYCOGEN_METABOLISM | 5.74e-05 | 21 | 270 | 4 | M10376 | |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | AFTPH PTPRJ NECTIN1 LRRC7 MIA3 DGKD MACROH2A1 GSK3B RIMBP2 R3HDM1 | 5.90e-05 | 206 | 270 | 10 | M2817 |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | AFTPH PTPRJ NECTIN1 LRRC7 MIA3 DGKD MACROH2A1 GSK3B RIMBP2 R3HDM1 | 6.40e-05 | 208 | 270 | 10 | MM581 |
| Coexpression | YU_MYC_TARGETS_UP | 6.96e-05 | 42 | 270 | 5 | MM1150 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGBP | CDHR1 BRCA1 ASPM SGO2 WNT5A FAT3 PRC1 CCNA2 GSTP1 LRP2 RACGAP1 TMPO | 7.22e-05 | 300 | 270 | 12 | M39059 |
| Coexpression | CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN | CDHR1 ECHDC1 COQ3 PICALM LPIN1 BRCA1 ASPM PSAT1 ABCF2 PRC1 CCNA2 RALY ARFGAP2 PDIA6 ERG28 G3BP1 AIFM1 QTRT1 ESPL1 | 7.31e-05 | 669 | 270 | 19 | M18635 |
| Coexpression | YU_MYC_TARGETS_UP | 7.81e-05 | 43 | 270 | 5 | M1249 | |
| Coexpression | SESTO_RESPONSE_TO_UV_C8 | 9.24e-05 | 71 | 270 | 6 | M2948 | |
| Coexpression | CUI_DEVELOPING_HEART_TRABECULAR_ATRIAL_CARDIOMYOCYTE | 1.06e-04 | 179 | 270 | 9 | M39308 | |
| Coexpression | GSE13173_UNTREATED_VS_IL12_TREATED_ACT_CD8_TCELL_DN | 1.11e-04 | 141 | 270 | 8 | M465 | |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | SIPA1L3 TENM2 CACNA1C FRAS1 POR CUBN TFDP2 TENM4 NSMF SLIT3 LRP2 CSMD1 CSPP1 CUX1 | 1.20e-04 | 417 | 270 | 14 | M39224 |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_2H_UP | 1.25e-04 | 183 | 270 | 9 | M2993 | |
| Coexpression | FAN_EMBRYONIC_CTX_ASTROCYTE_2 | 2.04e-04 | 154 | 270 | 8 | M39034 | |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_UP | NUP54 BRCA1 ASPM ARL14EP DEK GPD2 FLNB PSAT1 ABCF2 MACROH2A1 PRC1 TFDP1 CCNA2 EFNB2 RACGAP1 TMPO | 2.07e-04 | 550 | 270 | 16 | M16189 |
| Coexpression | GSE39556_CD8A_DC_VS_NK_CELL_DN | 2.26e-04 | 198 | 270 | 9 | M9407 | |
| Coexpression | GSE2405_0H_VS_9H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP | 2.26e-04 | 198 | 270 | 9 | M6217 | |
| Coexpression | PUJANA_BRCA_CENTERED_NETWORK | 2.27e-04 | 118 | 270 | 7 | M15305 | |
| Coexpression | GSE25088_WT_VS_STAT6_KO_MACROPHAGE_DN | 2.34e-04 | 199 | 270 | 9 | M8031 | |
| Coexpression | GSE25088_WT_VS_STAT6_KO_MACROPHAGE_IL4_STIM_DN | 2.34e-04 | 199 | 270 | 9 | M8029 | |
| Coexpression | GSE2585_CTEC_VS_THYMIC_MACROPHAGE_DN | ANKRD31 TBC1D5 NHLRC2 BIRC6 DYRK3 TBL1XR1 KMT2D LNPEP SLC6A20 | 2.34e-04 | 199 | 270 | 9 | M6264 |
| Coexpression | GSE3982_MAST_CELL_VS_NEUTROPHIL_UP | 2.34e-04 | 199 | 270 | 9 | M5432 | |
| Coexpression | GSE17301_CTRL_VS_48H_IFNA2_STIM_CD8_TCELL_UP | DENND4A AFTPH ZFYVE16 ACVR1 NFRKB CTC1 CEP192 TMEM43 TMEM131 | 2.43e-04 | 200 | 270 | 9 | M8038 |
| Coexpression | GSE10240_CTRL_VS_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP | 2.43e-04 | 200 | 270 | 9 | M302 | |
| Coexpression | GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP | 2.43e-04 | 200 | 270 | 9 | M3446 | |
| Coexpression | GSE29164_DAY3_VS_DAY7_CD8_TCELL_TREATED_MELANOMA_UP | DNAJC22 SVEP1 MAPK8IP3 TP53RK COL6A2 RALY SETD5 PRELP TRAPPC14 | 2.43e-04 | 200 | 270 | 9 | M8488 |
| Coexpression | GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_48H_UP | 2.43e-04 | 200 | 270 | 9 | M6032 | |
| Coexpression | GSE21670_STAT3_KO_VS_WT_CD4_TCELL_TGFB_TREATED_UP | 2.43e-04 | 200 | 270 | 9 | M7442 | |
| Coexpression | GSE30962_PRIMARY_VS_SECONDARY_ACUTE_LCMV_INF_CD8_TCELL_UP | 2.43e-04 | 200 | 270 | 9 | M5041 | |
| Coexpression | GSE3982_DC_VS_MAC_LPS_STIM_UP | 2.43e-04 | 200 | 270 | 9 | M5387 | |
| Coexpression | GSE23505_IL6_IL1_VS_IL6_IL1_IL23_TREATED_CD4_TCELL_UP | 2.43e-04 | 200 | 270 | 9 | M7869 | |
| Coexpression | CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY | 2.44e-04 | 30 | 270 | 4 | M10778 | |
| Coexpression | SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP | 2.65e-04 | 160 | 270 | 8 | M986 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | ABCA1 CHML ABCA9 BRCA1 PKHD1 OSBPL11 SGO2 PRC1 TFDP1 CCNA2 CSF1R RACGAP1 TMPO | 3.43e-11 | 166 | 272 | 13 | bb8135119dc37fdbba476599a56d368f422688dc |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | COL6A5 TENM2 ABCA9 SVEP1 CACNA1C COL6A2 FAT3 ABCA6 PRELP UNC5C SLIT3 PRKG1 | 2.79e-09 | 193 | 272 | 12 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a |
| ToppCell | tumor_Lung-B_lymphocytes-GC_B_cells_in_the_DZ|B_lymphocytes / Location, Cell class and cell subclass | ACY3 BRCA1 ASPM SGO2 DEK MACROH2A1 PRC1 TFDP1 CCNA2 RACGAP1 TMPO ESPL1 | 3.14e-09 | 195 | 272 | 12 | 339e81a3a5b1f71c0d15ef1ef0f6999378704923 |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | COL6A5 ABCA9 SVEP1 CACNA1C COL6A2 FRAS1 ADAMTS1 FAT3 ABCA6 PRELP SLIT3 PRKG1 | 4.17e-09 | 200 | 272 | 12 | aa1a35dcca3b799241eef4237f6eb94660e019f0 |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | COL6A5 ABCA9 SVEP1 CACNA1C COL6A2 FRAS1 ADAMTS1 FAT3 ABCA6 PRELP SLIT3 PRKG1 | 4.17e-09 | 200 | 272 | 12 | a510deaada669e690329183e18df02870bd204b3 |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | COL6A5 ABCA9 SVEP1 CACNA1C COL6A2 FRAS1 ADAMTS1 FAT3 ABCA6 PRELP SLIT3 PRKG1 | 4.17e-09 | 200 | 272 | 12 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYL4 COL6A5 SVEP1 PKHD1 USH2A FRAS1 FAT3 UNC5C LRP2 RIMBP2 HYDIN | 4.51e-09 | 160 | 272 | 11 | c381ec6be8cf887861cc18f831a20db42f953fe1 |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYL4 COL6A5 SVEP1 PKHD1 USH2A FRAS1 FAT3 UNC5C LRP2 RIMBP2 HYDIN | 4.51e-09 | 160 | 272 | 11 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | DENND4A MYO9A PICALM ABCA9 PTPRJ OSBPL11 ADAMTS1 FAT3 LARS2 CSF1R SLC7A5 | 1.15e-08 | 175 | 272 | 11 | 1ea6cf9da26601646f57fa14d558a5e9e1f0b345 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA4 OBSCN PKHD1 USH2A MGAM FRAS1 FAT3 TENM4 LRP2 CSMD1 HYDIN | 1.94e-08 | 184 | 272 | 11 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA4 OBSCN PKHD1 USH2A MGAM FRAS1 FAT3 TENM4 LRP2 CSMD1 HYDIN | 1.94e-08 | 184 | 272 | 11 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA4 OBSCN PKHD1 USH2A MGAM FRAS1 FAT3 TENM4 LRP2 CSMD1 HYDIN | 1.94e-08 | 184 | 272 | 11 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | APCDD1 LGR4 ABCA9 SVEP1 COL6A2 TENM4 ABCA6 PRELP UNC5C PRKG1 PCDH9 | 2.05e-08 | 185 | 272 | 11 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | XIRP1 OBSCN TENM2 PICALM MAPK8IP3 MYO18B CACNA1C POR DGKD DIP2C ALPK2 | 2.70e-08 | 190 | 272 | 11 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | TBC1D5 PTPRJ PKHD1 FRAS1 SH3RF1 CUBN LRP2 DIP2C PRKG1 MBD5 CUX1 | 3.00e-08 | 192 | 272 | 11 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | SIPA1L3 LGR4 PTPRJ PKHD1 FRAS1 SH3RF1 RALYL CUBN LRP2 DIP2C CUX1 | 3.17e-08 | 193 | 272 | 11 | 3866667dd221612589ae50f5c52f73a183a49ce6 |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | PDLIM7 ABCA9 SVEP1 CACNA1C COL6A2 MXRA5 TENM4 ABCA6 UNC5C SLIT3 PRKG1 | 3.34e-08 | 194 | 272 | 11 | 03a269f75a481ea54aea8e6444605db8d6df493d |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | COL6A5 ABCA9 SVEP1 CACNA1C COL6A2 ADAMTS1 FAT3 ABCA6 UNC5C SLIT3 PRKG1 | 3.52e-08 | 195 | 272 | 11 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | APCDD1 COL6A5 ABCA9 SVEP1 COL6A2 MXRA5 CPE ABCA6 SAMD11 PRELP SLIT3 | 3.71e-08 | 196 | 272 | 11 | e7bfd4fb400ae0c473131d0fa306c26be08a6d03 |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | APCDD1 COL6A5 ABCA9 SVEP1 COL6A2 MXRA5 CPE ABCA6 SAMD11 PRELP SLIT3 | 3.71e-08 | 196 | 272 | 11 | 85e5046f774537684e1443c0fc147d562b7068d0 |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | APCDD1 COL6A5 ABCA9 SVEP1 COL6A2 MXRA5 CPE ABCA6 SAMD11 PRELP SLIT3 | 3.71e-08 | 196 | 272 | 11 | 82fad623212d986a7fca3496faf3f8c8f5b83a11 |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | SVEP1 CACNA1C COL6A2 MXRA5 APBB2 TENM4 ABCA6 UNC5C SLIT3 DIP2C PRKG1 | 3.91e-08 | 197 | 272 | 11 | f1c8936986123a3151140c374fcd62d6705c530b |
| ToppCell | metastatic_Lymph_Node-B_lymphocytes-GC_B_cells_in_the_DZ|B_lymphocytes / Location, Cell class and cell subclass | ACY3 BRCA1 ASPM SGO2 DEK MACROH2A1 PRC1 TFDP1 CCNA2 GSTP1 RACGAP1 | 4.12e-08 | 198 | 272 | 11 | 21c4762ca8591804cf77a23b64470e60d25c5357 |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_granulocytic-granulocyte|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | BRCA1 ASPM SGO2 DEK BAHCC1 MACROH2A1 PRC1 CCNA2 GSTP1 RACGAP1 TMPO | 4.12e-08 | 198 | 272 | 11 | 2e669da80363163b806f23a645474d482797ae5d |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | COL6A5 ABCA9 SVEP1 CACNA1C COL6A2 ADAMTS1 FAT3 ABCA6 PRELP SLIT3 PRKG1 | 4.12e-08 | 198 | 272 | 11 | f1374f7a50244d59c766ac41f44c08c9117407d2 |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | COL6A5 ABCA9 SVEP1 CACNA1C COL6A2 FAT3 ABCA6 PRELP UNC5C SLIT3 PRKG1 | 4.12e-08 | 198 | 272 | 11 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 |
| ToppCell | B_cell_maturation-pre-B|B_cell_maturation / Lineage and Cell class | BRCA1 ASPM SGO2 DEK MACROH2A1 PRC1 TFDP1 TFDP2 CCNA2 RACGAP1 TMPO | 4.33e-08 | 199 | 272 | 11 | 4bf6a656de04d92103cbe743cd07afd9d125c654 |
| ToppCell | ILEUM-inflamed-(8)_Fibroblasts|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | APCDD1 COL6A5 SVEP1 COL6A2 FLNB MXRA5 ADAMTS1 ABCA6 UNC5C SLIT3 PRKG1 | 4.33e-08 | 199 | 272 | 11 | 3a3e2bb21cd0293622b1a975263e918d9ba24265 |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | COL6A5 ABCA9 SVEP1 CACNA1C COL6A2 ADAMTS1 FAT3 ABCA6 PRELP SLIT3 PRKG1 | 4.33e-08 | 199 | 272 | 11 | 66a79732caf2f04c09b4d9832377aa01ca477677 |
| ToppCell | ILEUM-inflamed-(1)_Highly_activated_T_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | BRCA1 ASPM SGO2 DEK MACROH2A1 PRC1 TFDP1 CCNA2 PPP1CA RACGAP1 TMPO | 4.56e-08 | 200 | 272 | 11 | 6ff811fdfe49b5b0aea0e88fae80bfaaf40eb7c4 |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | COL6A5 SVEP1 CACNA1C COL6A2 FRAS1 MXRA5 FAT3 ABCA6 PRELP SLIT3 PRKG1 | 4.56e-08 | 200 | 272 | 11 | 8c62f05c6042f24287a73fbdf80ff4a56f7ff403 |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-Undetermined|T/NK_cells / Location, Cell class and cell subclass | BRCA1 ASPM SGO2 DEK MACROH2A1 PRC1 TFDP1 CCNA2 RACGAP1 TMPO ESPL1 | 4.56e-08 | 200 | 272 | 11 | 9c2095dcf70f1288d55d0ff4a97efd4fd8d0c9ee |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | COL6A5 ABCA9 SVEP1 CACNA1C COL6A2 FAT3 ABCA6 UNC5C SLIT3 PRKG1 | 5.04e-08 | 158 | 272 | 10 | e5636c0b608d68bd426a2b446ac508e4512e86a4 |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | CEP295NL LGR4 COL6A5 SVEP1 VIPR2 COL6A2 FAT3 DDO CEP192 TENM4 | 1.00e-07 | 170 | 272 | 10 | ba4ba66b624089ed50a9083176386c7941b4c7a3 |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.71e-07 | 180 | 272 | 10 | 5e1680088065be14447d5d5465f91f7edd071a1e | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | COL6A5 TENM2 SVEP1 CACNA1C FRAS1 FAT3 ABCA6 UNC5C SLIT3 PRKG1 | 1.80e-07 | 181 | 272 | 10 | 9ede19228ba5c0668a9c06c915510b95585216ef |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | APCDD1 F8 ABCA9 SVEP1 CACNA1C COL6A2 TENM4 ABCA6 UNC5C PRKG1 | 1.90e-07 | 182 | 272 | 10 | fbd5e332df73bf7141c822fa67b76367dc962017 |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.00e-07 | 183 | 272 | 10 | d73cac83cde82665f110baad7cf28db75f9ffe52 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D122|Adult / Lineage, Cell type, age group and donor | APCDD1 ABCA9 SVEP1 VIPR2 COL6A2 ABCA6 SAMD11 PRELP UNC5C SLIT3 | 2.10e-07 | 184 | 272 | 10 | 2b7e6f91e11c228f0521e099886867d9e998e78d |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | APCDD1 ABCA9 SVEP1 COL6A2 TENM4 ABCA6 PRELP UNC5C PRKG1 PCDH9 | 2.56e-07 | 188 | 272 | 10 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 |
| ToppCell | (02)_Cycling_Basal_(regeneration)|World / shred by cell type and Timepoint | 2.83e-07 | 190 | 272 | 10 | 53f017a11ca5ebe9025558e12cedc409cab2e5aa | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.11e-07 | 192 | 272 | 10 | d0649410cf5eacdb0c1dce70e37c7473ef5fddfa | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-basal_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-07 | 192 | 272 | 10 | ec1fd2fb6e71f87189d66261909a84e2be63cacb | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | COL6A5 SVEP1 CACNA1C COL6A2 ADAMTS1 FAT3 ABCA6 UNC5C SLIT3 PRKG1 | 3.11e-07 | 192 | 272 | 10 | 3d0cb19f037f604253d7d728689aeaa94251e92b |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | ABCA9 SVEP1 CACNA1C COL6A2 FRAS1 FAT3 ABCA6 UNC5C SLIT3 PRKG1 | 3.11e-07 | 192 | 272 | 10 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | TENM2 ABCA9 SVEP1 CACNA1C COL6A2 FAT3 ABCA6 UNC5C SLIT3 PRKG1 | 3.27e-07 | 193 | 272 | 10 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | TENM2 SVEP1 CACNA1C COL6A2 FRAS1 FAT3 ABCA6 UNC5C SLIT3 PRKG1 | 3.27e-07 | 193 | 272 | 10 | acad568621ed677031797b8c2e34dafea798d681 |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | COL6A5 SVEP1 CACNA1C COL6A2 ADAMTS1 FAT3 ABCA6 UNC5C SLIT3 PRKG1 | 3.43e-07 | 194 | 272 | 10 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | COL6A5 SVEP1 LRRC7 CACNA1C COL6A2 FAT3 ABCA6 UNC5C SLIT3 PRKG1 | 3.43e-07 | 194 | 272 | 10 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.43e-07 | 194 | 272 | 10 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | APCDD1 LGR4 ABCA9 SVEP1 COL6A2 TENM4 ABCA6 PRELP UNC5C PRKG1 | 3.59e-07 | 195 | 272 | 10 | f423baa36ac7cdc383c033e35a7d17e6bf913323 |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | ABCA9 SVEP1 CACNA1C FRAS1 FAT3 APBB2 ABCA6 UNC5C SLIT3 PRKG1 | 3.59e-07 | 195 | 272 | 10 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | ABCA9 SVEP1 CACNA1C COL6A2 ADAMTS1 FAT3 ABCA6 UNC5C SLIT3 PRKG1 | 3.59e-07 | 195 | 272 | 10 | aa0add081881d349099d12efca5cdee098038d4e |
| ToppCell | Nasal_Brush-Epithelial-Club|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.73e-07 | 150 | 272 | 9 | d39d73a1de6a873292d48e469d9403f513045be3 | |
| ToppCell | Nasal_Brush-Epithelial-Club|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.73e-07 | 150 | 272 | 9 | c68645ffcffe524cf1d9736cf72a15b37ed8dc3d | |
| ToppCell | COVID-19-kidney-TAL|kidney / Disease (COVID-19 only), tissue and cell type | 3.77e-07 | 196 | 272 | 10 | 04f5eb206ed3016a737609a3ebac0c1fcabb94ef | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | COL6A5 ABCA9 SVEP1 COL6A2 ADAMTS1 FAT3 ABCA6 PRELP SLIT3 PRKG1 | 3.77e-07 | 196 | 272 | 10 | 9737a5f006d37b549f281e1863aca558e1e4dc99 |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | COL6A5 ABCA9 SVEP1 COL6A2 ADAMTS1 FAT3 ABCA6 PRELP SLIT3 PRKG1 | 3.77e-07 | 196 | 272 | 10 | cecf82cd5e0a3835d655f5e7478578674a63ce25 |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | ABCA9 SVEP1 CACNA1C COL6A2 FAT3 ABCA6 PRELP UNC5C SLIT3 PRKG1 | 3.77e-07 | 196 | 272 | 10 | 7d8505dac15fa59935ccf592afc54b04c4c6554f |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | ABCA9 SVEP1 CACNA1C COL6A2 APBB2 ABCA6 UNC5C SLIT3 DIP2C PRKG1 | 3.95e-07 | 197 | 272 | 10 | fb847f2277609c31fffcdf49517243ce0684facf |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | ABCA9 SVEP1 CACNA1C COL6A2 FRAS1 ABCA6 PRELP UNC5C SLIT3 PRKG1 | 4.13e-07 | 198 | 272 | 10 | df3de77216f5c5d6141ec44d01c56b942f611838 |
| ToppCell | normal_Lymph_Node-T/NK_cells-Undetermined|T/NK_cells / Location, Cell class and cell subclass | 4.13e-07 | 198 | 272 | 10 | 47d572b9db2843aeb2079f33a852babf67270be4 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | MYO9A TBC1D5 SIPA1L3 SH3RF1 SMURF1 APBB2 DIP2C PRKG1 MBD5 CUX1 | 4.13e-07 | 198 | 272 | 10 | 1996373bdccc55aac347d349bd22f6aad6d0c668 |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | ABCA9 SVEP1 CACNA1C COL6A2 FAT3 ABCA6 PRELP UNC5C SLIT3 PRKG1 | 4.13e-07 | 198 | 272 | 10 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | SVEP1 CACNA1C COL6A2 MXRA5 ADAMTS1 FAT3 PRELP UNC5C PRKG1 PCDH9 | 4.13e-07 | 198 | 272 | 10 | bd11b0e9e80449aab979a02c1023e0638c431c7c |
| ToppCell | normal_Lung-T/NK_cells-Undetermined|T/NK_cells / Location, Cell class and cell subclass | 4.33e-07 | 199 | 272 | 10 | 4142d5b1b20212508f95841fdac4efb7655616cb | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | DYM TBC1D5 SIPA1L3 BIRC6 ITPR2 PTPRJ APBB2 TBL1XR1 DIP2C MBD5 | 4.33e-07 | 199 | 272 | 10 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | APCDD1 COL6A5 ABCA9 SVEP1 COL6A2 MXRA5 CPE ABCA6 SAMD11 PRELP | 4.33e-07 | 199 | 272 | 10 | fb580e9321ddf97c73b2e356cd82523db74a38a2 |
| ToppCell | COVID-19-kidney-Fibroblast-1|kidney / Disease (COVID-19 only), tissue and cell type | ABCA1 ABCA9 SVEP1 CACNA1C COL6A2 RASA3 ABCA6 PRELP SLIT3 PRKG1 | 4.33e-07 | 199 | 272 | 10 | 9503646ff1ad248181146ce767e9d12e882ec3bd |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | ABCA9 SVEP1 CACNA1C COL6A2 ADAMTS1 FAT3 ABCA6 UNC5C SLIT3 PRKG1 | 4.33e-07 | 199 | 272 | 10 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblasts|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | COL6A5 SVEP1 COL6A2 FLNB MXRA5 ADAMTS1 ABCA6 UNC5C SLIT3 PRKG1 | 4.33e-07 | 199 | 272 | 10 | d9d7f36b4b5592b7855448730044c90997b55499 |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Mesothelial-1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | EPHB6 DNAJC22 SVEP1 FBXO32 VIPR2 COL6A2 FRAS1 ADAMTS1 CPE SLIT3 | 4.53e-07 | 200 | 272 | 10 | c800f20adedf4ca736c740510889e92d8bf0ba44 |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ABCA9 SVEP1 CACNA1C COL6A2 ADAMTS1 FAT3 ABCA6 PRELP UNC5C SLIT3 | 4.53e-07 | 200 | 272 | 10 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Mesothelial-1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | EPHB6 DNAJC22 SVEP1 FBXO32 VIPR2 COL6A2 FRAS1 ADAMTS1 CPE SLIT3 | 4.53e-07 | 200 | 272 | 10 | bf50e30d5cafb71c567e89580f62084d2f894170 |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ABCA9 SVEP1 CACNA1C COL6A2 FRAS1 FAT3 ABCA6 PRELP UNC5C SLIT3 | 4.53e-07 | 200 | 272 | 10 | 34f52003988ce6329d8deeee1ab875fa77e01e9d |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | PDLIM7 SACS FBXO32 CACNA1C COL6A2 ADAMTS1 FAT3 CPE SLIT3 PRKG1 | 4.53e-07 | 200 | 272 | 10 | a66449b22b39dd6987fc2c3ed160d24564234ced |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-1|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | COL6A5 CACNA1C COL6A2 MXRA5 CPE ABCA6 SAMD11 PRELP SLIT3 PRKG1 | 4.53e-07 | 200 | 272 | 10 | 16a3685c41194a0a4a772e4eee372160263480e0 |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Mesothelial-1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | EPHB6 DNAJC22 SVEP1 FBXO32 VIPR2 COL6A2 FRAS1 ADAMTS1 CPE SLIT3 | 4.53e-07 | 200 | 272 | 10 | 5e5ad07679d5dd2ca80249bce9aaf4a95d42187b |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.48e-07 | 157 | 272 | 9 | f147e24f2ece82e1c54750868954d09b3c461804 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Fibroblasts-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.78e-07 | 158 | 272 | 9 | 7f5426585d0d299d2b48e5fcb349950feffdef33 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 6.77e-07 | 161 | 272 | 9 | 64891f6f2ee1693c8481e951b9346e2f92d602e3 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.13e-07 | 162 | 272 | 9 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.20e-07 | 167 | 272 | 9 | a90f905ef38437752e2b0b71bd0322a184de1861 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-06 | 169 | 272 | 9 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | -Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 1.23e-06 | 173 | 272 | 9 | 88be9182fbb1bc83531cd41e59ea57c112a21d54 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.23e-06 | 173 | 272 | 9 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-06 | 173 | 272 | 9 | 869da6a65d1b9b7529c666ec44e3c8ddec2ea408 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-06 | 173 | 272 | 9 | 0672bd8a4a9d18af343d01f09253fb3388896c10 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-06 | 173 | 272 | 9 | 870e091ec30be01a900e1cb8b9ef1880e3b7b50d | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 1.29e-06 | 174 | 272 | 9 | fa0681e91724b9a51ee28b214ea5aa14e62ba1a3 | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-06 | 175 | 272 | 9 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.49e-06 | 177 | 272 | 9 | a68c3688f12aee22f3cb4049c4bccacbacb0fae6 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.64e-06 | 179 | 272 | 9 | 54191c00b29f53b520cd3243b5791daa4a2c72d7 | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 1.71e-06 | 180 | 272 | 9 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 1.88e-06 | 182 | 272 | 9 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | COVID-19-Heart-CM_4|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.96e-06 | 183 | 272 | 9 | 2902b6e8aa9a6f62bc1a792c971ab7f651a8e676 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.15e-06 | 185 | 272 | 9 | 7dcdc009c5681ee05dd18968f7e85c3403fe34af | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | PDLIM7 GALNT18 MTCL1 CACNA1C COL6A2 RASA3 ADAMTS1 DGKD DIP2C | 2.15e-06 | 185 | 272 | 9 | e58a009aaf342be019a909747b1895d5987d4daf |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.25e-06 | 186 | 272 | 9 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.25e-06 | 186 | 272 | 9 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| Drug | Isoxsuprine hydrochloride [579-56-6]; Down 200; 11.8uM; MCF7; HT_HG-U133A | ERN1 SIPA1L3 RBM48 SRCAP PHKA2 DYRK3 CTC1 BICRA ABCF2 LRP2 TRAPPC14 QTRT1 CSPP1 | 7.14e-07 | 197 | 270 | 13 | 1485_DN |
| Drug | Hesperidin [520-26-3]; Down 200; 6.6uM; PC3; HT_HG-U133A | PDLIM7 TBC1D5 RBM48 SLC7A11 PICALM STAT1 LPIN1 BRCA1 NFRKB SEC23A TFDP2 CSPP1 | 3.38e-06 | 192 | 270 | 12 | 6714_DN |
| Drug | Propafenone hydrochloride [34183-22-7]; Up 200; 10.6uM; MCF7; HT_HG-U133A | SLC7A11 LPIN1 ZFYVE9 NECTIN1 NOS1 KIF13B DDX60 EFHC2 PPP2R5B MED25 R3HDM1 PCDH9 | 3.56e-06 | 193 | 270 | 12 | 5437_UP |
| Drug | AC1LCY75 | 3.84e-06 | 10 | 270 | 4 | CID000639298 | |
| Drug | Phenylpropanolamine hydrochloride [154-41-6]; Down 200; 21.4uM; MCF7; HT_HG-U133A | PDE4A MYL4 SIPA1L3 SRCAP PHKA2 BAHCC1 BICRA APBB2 TBC1D17 LNPEP EIF4G2 PCDH9 | 4.18e-06 | 196 | 270 | 12 | 3217_DN |
| Drug | Tetracycline hydrochloride [64-75-5]; Down 200; 8.4uM; PC3; HT_HG-U133A | HIVEP1 PDLIM7 SRCAP SVEP1 MAPK8IP3 ITPR2 ZFYVE9 DOCK6 BAHCC1 ABCF2 PPP2R5B TRAPPC14 | 4.18e-06 | 196 | 270 | 12 | 5757_DN |
| Drug | 17-DMAG; Down 200; 0.1uM; HL60; HT_HG-U133A | KDM3B CHML NFRKB BAHCC1 RALGDS FLNB LILRA2 ABCF2 PPM1A EFNB2 NSMF QTRT1 | 4.40e-06 | 197 | 270 | 12 | 1154_DN |
| Drug | Dimenhydrinate [523-87-5]; Down 200; 8.6uM; HL60; HT_HG-U133A | ZFYVE16 TBC1D5 ZFYVE9 CLCN6 SEC23A RALGDS DDX60 POR TFDP2 MED25 LRP2 PRKG2 | 4.89e-06 | 199 | 270 | 12 | 2400_DN |
| Drug | Levonordefrin [829-74-3]; Down 200; 21.8uM; PC3; HT_HG-U133A | SIPA1L3 F8 INTS15 DYRK3 COL6A2 BICRA APBB2 TFDP2 TENM4 HPS6 QTRT1 | 2.16e-05 | 194 | 270 | 11 | 5854_DN |
| Drug | Acebutolol hydrochloride [34381-68-5]; Up 200; 10.8uM; PC3; HG-U133A | MYO9A SIPA1L3 SRCAP INTS15 TAF12 SEC23A DYRK3 APBB2 PPP2R5B MED25 QTRT1 | 2.27e-05 | 195 | 270 | 11 | 1911_UP |
| Drug | Sulfamethoxypyridazine [80-35-3]; Down 200; 14.2uM; MCF7; HT_HG-U133A | PDE4A PDLIM7 RBM48 SLC7A11 BRCA1 BICRA SMURF1 HPS6 TRAPPC14 QTRT1 CSPP1 | 2.27e-05 | 195 | 270 | 11 | 3409_DN |
| Drug | Timolol maleate salt [26921-17-5]; Down 200; 9.2uM; MCF7; HT_HG-U133A | MYL4 PDLIM7 TBC1D5 SRCAP SVEP1 ZFYVE9 WNT5A GSTP1 PPP2R5B ERG28 LRP2 | 2.38e-05 | 196 | 270 | 11 | 5280_DN |
| Drug | Hydrochlorothiazide [58-93-5]; Down 200; 13.4uM; MCF7; HT_HG-U133A | ERN1 PDLIM7 CHML WLS PHKA2 ZFYVE9 NFRKB CTC1 SMURF1 PPM1A CSPP1 | 2.38e-05 | 196 | 270 | 11 | 1487_DN |
| Drug | 8-mercapto-FAD | 2.38e-05 | 15 | 270 | 4 | CID003037229 | |
| Drug | Gelsemine [509-15-9]; Down 200; 12.4uM; MCF7; HT_HG-U133A | MYL4 SIPA1L3 CHML SLC7A11 CLCN6 INTS15 MIA3 LARS2 NSMF TRAPPC14 QTRT1 | 2.61e-05 | 198 | 270 | 11 | 2817_DN |
| Drug | Selegiline hydrochloride [14611-52-0]; Down 200; 17.8uM; PC3; HT_HG-U133A | MYL4 SRCAP SVEP1 VIPR2 TENM4 PRELP TTLL4 SLC6A20 EIF4G2 LRP2 R3HDM1 | 2.73e-05 | 199 | 270 | 11 | 4065_DN |
| Drug | Alprenolol hydrochloride [13707-88-5]; Up 200; 14uM; PC3; HT_HG-U133A | PDE4A PDLIM7 SIPA1L3 BAHCC1 APBB2 CPE TFDP2 TBC1D17 LNPEP TRAPPC14 CSPP1 | 2.73e-05 | 199 | 270 | 11 | 7141_UP |
| Drug | oligomycin; Up 200; 1uM; MCF7; HG-U133A | SLC7A11 PHKA2 BRCA1 MIPEP DYRK3 BAHCC1 FRAS1 BICRA CEP192 ERG28 SLIT3 | 2.73e-05 | 199 | 270 | 11 | 442_UP |
| Drug | Diazoxide [364-98-7]; Down 200; 17.4uM; MCF7; HT_HG-U133A | MYL4 PDLIM7 SRCAP SLC7A11 ZFYVE9 NOS1 KIF13B ABCF2 PPM1A PPP2R5B TRAPPC14 | 2.73e-05 | 199 | 270 | 11 | 2214_DN |
| Drug | 4-hydroxy-2-nonenal | ABCA1 ERN1 CHML SLC7A11 STAT1 LPIN1 NECTIN1 NFRKB ASPM SGO2 REV1 RALGDS APEX1 CPE TBL1XR1 GSK3B TFDP2 CCNA2 PPP1CA GSTP1 CSF1R AIFM1 ESPL1 CUX1 | 3.10e-05 | 798 | 270 | 24 | ctd:C027576 |
| Drug | PTAD | 5.57e-05 | 7 | 270 | 3 | CID000077913 | |
| Drug | digitonine | 5.57e-05 | 7 | 270 | 3 | CID000025444 | |
| Drug | tetradecylamine | 5.57e-05 | 7 | 270 | 3 | CID000016217 | |
| Drug | Methamphetamine | ERN1 ZFYVE16 PDLIM7 OBSCN LGR4 NHLRC2 SLC7A11 MAPK8IP3 ITPR2 TMX1 FCGBP BRCA1 CLCN6 ASPM ARL14EP FBXO32 MYO18B DOCK6 USH2A NOS1 CACNA1C FLNB PSAT1 PLEKHG2 CUBN CCNA2 RALY GSTP1 NSMF TTLL4 EIF4G2 PRKG1 CSMD1 CUX1 | 5.89e-05 | 1401 | 270 | 34 | ctd:D008694 |
| Drug | Zuclopenthixol hydrochloride [633-59-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A | MYL4 SRCAP SLC7A11 SVEP1 LPIN1 NFRKB MTCL1 SEC23A KIF13B TMPO | 6.97e-05 | 183 | 270 | 10 | 4843_UP |
| Drug | 9-fluorenol | 8.84e-05 | 8 | 270 | 3 | CID000074318 | |
| Drug | NSC374898 | 8.84e-05 | 8 | 270 | 3 | CID005351331 | |
| Drug | radicicol, diheterospora chlamydosporia; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | PDE4A SLC7A11 MAPK8IP3 LPIN1 ZFYVE9 DOCK6 RALGDS LARS2 PPP2R5B R3HDM1 | 9.53e-05 | 190 | 270 | 10 | 999_UP |
| Drug | Bi-O | 9.87e-05 | 21 | 270 | 4 | CID005287844 | |
| Drug | strictosidine | 9.87e-05 | 21 | 270 | 4 | CID000161336 | |
| Drug | aflodac | DYM ERN1 PDLIM7 LARP4 COL6A2 ENPP7 GSK3B CCNA2 TG AIFM1 PRKG1 PRKG2 | 1.03e-04 | 271 | 270 | 12 | CID000005352 |
| Drug | Prednisolone [50-24-8]; Down 200; 11uM; PC3; HT_HG-U133A | MYL4 TBC1D5 SLC7A11 STAT1 LPIN1 DIP2A LARS2 TENM4 PRKG2 CSPP1 | 1.08e-04 | 193 | 270 | 10 | 5101_DN |
| Drug | Ethopropazine hydrochloride [1094-08-2]; Down 200; 11.4uM; PC3; HT_HG-U133A | ABCA1 MYL4 ZFYVE16 SIPA1L3 ITPR2 ZFYVE9 RALGDS BICRA WNT5A TENM4 | 1.08e-04 | 193 | 270 | 10 | 6697_DN |
| Drug | 5707885; Up 200; 50uM; MCF7; HT_HG-U133A | ABCA1 SRCAP SLC7A11 SVEP1 LPIN1 DOCK6 GPD2 PCDHGA10 PCDHGA1 PPM1E | 1.13e-04 | 194 | 270 | 10 | 6385_UP |
| Drug | Adamantamine fumarate [80789-67-9]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 1.13e-04 | 194 | 270 | 10 | 3280_DN | |
| Drug | 5707885; Up 200; 50uM; MCF7; HT_HG-U133A | MYL4 SIPA1L3 SLC7A11 PICALM STAT1 ZFYVE9 VIPR2 APBB2 PPP2R5B LRP2 | 1.18e-04 | 195 | 270 | 10 | 6433_UP |
| Drug | Rimexolone [49697-38-3]; Down 200; 10.8uM; PC3; HT_HG-U133A | EPHB6 DENND4A SIPA1L3 RBM48 CHML DIP2A GPD2 DDX60 TENM4 PRKG2 | 1.18e-04 | 195 | 270 | 10 | 5092_DN |
| Drug | Lisinopril [83915-83-7]; Up 200; 9uM; MCF7; HT_HG-U133A | MYL4 PHF8 SLC7A11 F8 NOS1 KIF13B APBB2 PPP2R5B TRAPPC14 CSPP1 | 1.18e-04 | 195 | 270 | 10 | 7403_UP |
| Drug | Meclozine dihydrochloride [1104-22-9]; Down 200; 8.6uM; PC3; HT_HG-U133A | ABCA1 TBC1D5 STAT1 LPIN1 NFRKB GPD2 COL6A2 RALGDS DDX60 CSPP1 | 1.18e-04 | 195 | 270 | 10 | 4646_DN |
| Drug | Folic acid [59-30-3]; Up 200; 9uM; MCF7; HT_HG-U133A | 1.18e-04 | 195 | 270 | 10 | 7201_UP | |
| Drug | Metrizamide [31112-62-6]; Up 200; 5uM; HL60; HT_HG-U133A | ZFYVE16 SIPA1L3 CHML PICALM STAT1 ITPR2 TMX1 RASA3 PPM1E TMPO | 1.18e-04 | 195 | 270 | 10 | 1318_UP |
| Drug | Ozagrel hydrochloride [78712-43-3]; Down 200; 15.2uM; HL60; HT_HG-U133A | MYL4 ERN1 PDLIM7 SIPA1L3 SLC7A11 SMURF1 TBC1D17 PRELP EIF4G2 TRAPPC14 | 1.23e-04 | 196 | 270 | 10 | 2942_DN |
| Drug | Felodipine [72509-76-3]; Down 200; 10.4uM; MCF7; HT_HG-U133A | PDLIM7 LGR4 PHF8 ITPR2 LPIN1 SEC23A EBLN2 RALGAPB ERG28 PCDH9 | 1.23e-04 | 196 | 270 | 10 | 5294_DN |
| Drug | Trimethoprim [738-70-5]; Down 200; 13.8uM; PC3; HT_HG-U133A | 1.23e-04 | 196 | 270 | 10 | 7377_DN | |
| Drug | sodium 4-phenylbutyrate; Down 200; 100uM; MCF7; HG-U133A | SRCAP SLC7A11 SVEP1 ITPR2 POGLUT1 INTS15 DYRK3 RASA3 LARS2 PCDH9 | 1.23e-04 | 196 | 270 | 10 | 341_DN |
| Drug | Methotrimeprazine maleat salt [7104-38-3]; Down 200; 9uM; MCF7; HT_HG-U133A | MYL4 SIPA1L3 SRCAP MAPK8IP3 ZFYVE9 CLCN6 VIPR2 APBB2 PPP2R5B CSF1R | 1.23e-04 | 196 | 270 | 10 | 4723_DN |
| Drug | Deferoxamine mesylate [138-14-7]; Down 200; 6uM; MCF7; HT_HG-U133A | ABCA1 PDLIM7 SIPA1L3 CLCN6 BAHCC1 VIPR2 MIA3 CTC1 ABCF2 CSF1R | 1.23e-04 | 196 | 270 | 10 | 3936_DN |
| Drug | Flumequine [42835-25-6]; Down 200; 15.4uM; HL60; HG-U133A | DENND4A MYO9A SLC7A11 STAT1 BRCA1 MIPEP MGAM CCNA2 RACGAP1 R3HDM1 | 1.28e-04 | 197 | 270 | 10 | 1429_DN |
| Drug | Clebopride maleate [84370-95-6]; Down 200; 8.2uM; MCF7; HT_HG-U133A | MYL4 STAT1 ITPR2 POGLUT1 ZFYVE9 SEC23A SMURF1 MED25 QTRT1 CSPP1 | 1.28e-04 | 197 | 270 | 10 | 2646_DN |
| Drug | Ciprofloxacin hydrochloride [93107-08-5]; Up 200; 10.8uM; HL60; HG-U133A | RBM48 CLCN6 NOS1 ADAMTS1 BICRA ABCF2 CUBN TTLL4 TRAPPC14 R3HDM1 | 1.28e-04 | 197 | 270 | 10 | 2022_UP |
| Drug | Parbendazole [14255-87-9]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 1.28e-04 | 197 | 270 | 10 | 3881_UP | |
| Drug | clozapine; Down 200; 10uM; HL60; HT_HG-U133A | PDE4A PDLIM7 SLC7A11 SVEP1 RASA3 DDX60 RALGAPB MED25 TRAPPC14 CSPP1 | 1.28e-04 | 197 | 270 | 10 | 2689_DN |
| Drug | Beta-sistosterol [83-46-5]; Down 200; 9.6uM; MCF7; HT_HG-U133A | PDLIM7 SIPA1L3 F8 STAT1 INTS15 SEC23A KIF13B SMURF1 TBC1D17 ZMYM4 | 1.28e-04 | 197 | 270 | 10 | 7332_DN |
| Drug | Cefoxitin sodium salt [33564-30-6]; Up 200; 8.8uM; PC3; HT_HG-U133A | ABCA1 DENND4A MYL4 DOCK6 EBLN2 SMURF1 TBC1D17 LNPEP TRAPPC14 CUX1 | 1.28e-04 | 197 | 270 | 10 | 7148_UP |
| Drug | Lobeline alpha (-) hydrochoride [134-63-4]; Down 200; 10.6uM; MCF7; HT_HG-U133A | SIPA1L3 SRCAP SLC7A11 ITPR2 INTS15 CTC1 BICRA DGKD TTLL4 QTRT1 | 1.28e-04 | 197 | 270 | 10 | 2763_DN |
| Drug | Diazoxide [364-98-7]; Down 200; 17.4uM; PC3; HT_HG-U133A | TBC1D5 SIPA1L3 PICALM TAF12 GPD2 SMURF1 PPP2R5B DIP2C TMPO ZMYM3 | 1.28e-04 | 197 | 270 | 10 | 2052_DN |
| Drug | Cyanocobalamin [68-19-9]; Up 200; 3uM; HL60; HT_HG-U133A | PDLIM7 SIPA1L3 NHLRC2 CHML ZFYVE9 RASA3 ABCF2 MED25 TRAPPC14 QTRT1 | 1.28e-04 | 197 | 270 | 10 | 1315_UP |
| Drug | Lovastatin [75330-75-5]; Down 200; 9.8uM; HL60; HT_HG-U133A | ABCA1 MYL4 PDLIM7 CHML ITPR2 DOCK6 VIPR2 ERG28 LRP2 TRAPPC14 | 1.28e-04 | 197 | 270 | 10 | 2494_DN |
| Drug | prochlorperazine dimaleate salt; Down 200; 10uM; MCF7; HT_HG-U133A | 1.28e-04 | 197 | 270 | 10 | 1640_DN | |
| Drug | GC-MPT | 1.31e-04 | 9 | 270 | 3 | CID000194264 | |
| Drug | tibric acid | 1.31e-04 | 9 | 270 | 3 | CID000032335 | |
| Drug | Pentolinium bitartrate [52-62-0]; Up 200; 7.4uM; PC3; HT_HG-U133A | SIPA1L3 DIP2A DOCK6 DDX60 SMURF1 DDO CSF1R PRKG2 R3HDM1 CSPP1 | 1.34e-04 | 198 | 270 | 10 | 7375_UP |
| Drug | Pyrimethamine [58-14-0]; Up 200; 16uM; MCF7; HT_HG-U133A | DENND4A SIPA1L3 CHML SLC7A11 PICALM SEC23A DYRK3 DDX60 CPE MED25 | 1.34e-04 | 198 | 270 | 10 | 4779_UP |
| Drug | SR-95639A [115767-94-7]; Up 200; 10uM; MCF7; HT_HG-U133A | EPHB6 MYL4 DNAJC22 SLC7A11 BRCA1 DOCK6 MIA3 ABCF2 CSF1R MED25 | 1.34e-04 | 198 | 270 | 10 | 4977_UP |
| Drug | Mefenamic acid [61-68-7]; Up 200; 16.6uM; HL60; HT_HG-U133A | MYL4 ZFYVE16 PDLIM7 PHKA2 RASA3 RALGAPB PPM1A CCNA2 TRAPPC14 QTRT1 | 1.40e-04 | 199 | 270 | 10 | 1863_UP |
| Drug | nordihydroguaiaretic acid; Down 200; 1uM; MCF7; HT_HG-U133A | SIPA1L3 LGR4 DIP2A INTS15 MTCL1 SEC23A BICRA TBC1D17 IFNGR2 TRAPPC14 | 1.40e-04 | 199 | 270 | 10 | 6942_DN |
| Drug | Folinic acid calcium salt [6035-45-6]; Down 200; 7.8uM; MCF7; HT_HG-U133A | SIPA1L3 SRCAP MAPK8IP3 CLCN6 BAHCC1 VIPR2 PPP2R5B ERG28 CSF1R SLC6A20 | 1.40e-04 | 199 | 270 | 10 | 4725_DN |
| Drug | Diphemanil methylsulfate [62-97-5]; Up 200; 10.2uM; HL60; HG-U133A | SRCAP PICALM STAT1 MAPK8IP3 MGAM MIA3 TFDP2 DIP2C TMPO QTRT1 | 1.40e-04 | 199 | 270 | 10 | 1994_UP |
| Drug | Tetrahydrozoline hydrochloride [522-48-5]; Down 200; 16.8uM; MCF7; HT_HG-U133A | MYO9A CHML WLS LPIN1 VIPR2 RALGDS SMURF1 APBB2 TBC1D17 CSF1R | 1.40e-04 | 199 | 270 | 10 | 6069_DN |
| Drug | Josamycin [16846-24-5]; Up 200; 4.8uM; MCF7; HT_HG-U133A | MYL4 SRCAP SVEP1 DYRK3 BAHCC1 KIF13B APBB2 PPP2R5B HPS6 PRKG2 | 1.40e-04 | 199 | 270 | 10 | 1534_UP |
| Drug | Guanabenz acetate [23256-50-0]; Down 200; 13.8uM; HL60; HG-U133A | 1.40e-04 | 199 | 270 | 10 | 2045_DN | |
| Drug | calcium citrate | 1.40e-04 | 2 | 270 | 2 | CID000013136 | |
| Drug | tetraheptylammonium | 1.40e-04 | 2 | 270 | 2 | CID000077071 | |
| Drug | K 901 | 1.40e-04 | 2 | 270 | 2 | CID000028055 | |
| Drug | 2-bromo-6-chloropurine | 1.40e-04 | 2 | 270 | 2 | CID005287744 | |
| Drug | Drotaverine | 1.40e-04 | 2 | 270 | 2 | DB06751 | |
| Drug | 3'-Ac-T2 | 1.40e-04 | 2 | 270 | 2 | CID000146779 | |
| Drug | adipostatin B | 1.40e-04 | 2 | 270 | 2 | CID000132615 | |
| Drug | Phentolamine hydrochloride [73-05-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A | SIPA1L3 WLS SLC7A11 MAPK8IP3 CLCN6 INTS15 DYRK3 LNPEP TRAPPC14 PCDH9 | 1.45e-04 | 200 | 270 | 10 | 2323_DN |
| Drug | miglustat | 1.58e-04 | 97 | 270 | 7 | CID000051634 | |
| Drug | Pimozide [2062-78-4]; Up 200; 8.6uM; MCF7; HT_HG-U133A | SRCAP SLC7A11 LPIN1 ZFYVE9 CLCN6 DDX60 TBC1D17 PPP2R5B ERG28 | 1.70e-04 | 166 | 270 | 9 | 6780_UP |
| Disease | mental development measurement | 2.35e-06 | 25 | 260 | 5 | EFO_0008230 | |
| Disease | stomach cancer (is_marker_for) | 5.02e-06 | 142 | 260 | 9 | DOID:10534 (is_marker_for) | |
| Disease | Malignant neoplasm of breast | XIRP1 ABCA4 PDLIM7 OBSCN ACVR1 STAT1 BRCA1 KCNH1 BTK OSBPL11 MAP7D2 LRRC7 DEK FLNB ADAMTS1 PPM1E RALYL DDO CUBN PRC1 GSTP1 KMT2D CSF1R DIP2C CUX1 | 1.09e-05 | 1074 | 260 | 25 | C0006142 |
| Disease | Schizophrenia | ABCA1 PDE4A DYM FAM3D BRCA1 NOS1 CACNA1C VIPR2 PSAT1 DDO LARS2 GSK3B CCNA2 GSTP1 TENM4 EFNB2 UNC5C SLIT3 ERVK-8 LRP2 CSMD1 GABRA6 | 1.34e-05 | 883 | 260 | 22 | C0036341 |
| Disease | Colorectal Carcinoma | EPHB6 ABCA1 ABCA4 OBSCN ABCA9 LRRC47 LPIN1 SACS PKHD1 RALGDS PPM1E CPE CUBN ABCA6 LRP2 DIP2C ZMYM4 CUX1 GABRA6 | 1.72e-05 | 702 | 260 | 19 | C0009402 |
| Disease | uric acid measurement | ABCA1 MYO9A SIPA1L3 ACVR1 BIRC6 TENM2 FRAS1 FAT3 CUBN TFDP2 PPM1A GBA3 PPP2R5B ABCA6 LRP2 DIP2C ZMYM3 | 3.34e-05 | 610 | 260 | 17 | EFO_0004761 |
| Disease | open-angle glaucoma | 5.33e-05 | 191 | 260 | 9 | EFO_0004190 | |
| Disease | Amphetamine-Related Disorders | 5.35e-05 | 75 | 260 | 6 | C0236733 | |
| Disease | Amphetamine Abuse | 5.35e-05 | 75 | 260 | 6 | C0236807 | |
| Disease | Amphetamine Addiction | 5.35e-05 | 75 | 260 | 6 | C0236804 | |
| Disease | Robinow syndrome (implicated_via_orthology) | 7.73e-05 | 2 | 260 | 2 | DOID:0060254 (implicated_via_orthology) | |
| Disease | esterified cholesterol measurement | 1.45e-04 | 128 | 260 | 7 | EFO_0008589 | |
| Disease | lipid measurement, intermediate density lipoprotein measurement | 2.11e-04 | 96 | 260 | 6 | EFO_0004529, EFO_0008595 | |
| Disease | Graves' disease (is_implicated_in) | 3.80e-04 | 39 | 260 | 4 | DOID:12361 (is_implicated_in) | |
| Disease | childhood trauma measurement, alcohol consumption measurement | 4.14e-04 | 71 | 260 | 5 | EFO_0007878, EFO_0007979 | |
| Disease | potassium voltage-gated channel subfamily E regulatory beta subunit 5 measurement | 4.59e-04 | 4 | 260 | 2 | EFO_0801902 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 6.61e-04 | 45 | 260 | 4 | DOID:3748 (is_implicated_in) | |
| Disease | loneliness measurement | 8.29e-04 | 124 | 260 | 6 | EFO_0007865 | |
| Disease | Tourette syndrome | 9.87e-04 | 50 | 260 | 4 | EFO_0004895 | |
| Disease | Sarcosine measurement | 1.05e-03 | 23 | 260 | 3 | EFO_0021668 | |
| Disease | response to surgery, post-operative sign or symptom | 1.13e-03 | 6 | 260 | 2 | EFO_0005323, EFO_0009951 | |
| Disease | aspartate aminotransferase measurement | ANKRD31 ABCA1 ABCA4 TBC1D5 OBSCN NHLRC2 BIRC6 LPIN1 BRCA1 PTPRJ PNP FLNB INPP5F CUBN GBA3 CSF1R CSMD1 ALPK2 | 1.19e-03 | 904 | 260 | 18 | EFO_0004736 |
| Disease | lung squamous cell carcinoma (is_implicated_in) | 1.19e-03 | 24 | 260 | 3 | DOID:3907 (is_implicated_in) | |
| Disease | serum selenium measurement | 1.23e-03 | 53 | 260 | 4 | EFO_0005266 | |
| Disease | urate measurement, bone density | COL6A5 TENM2 GALNT18 ITPR2 A2ML1 MIPEP USH2A VIPR2 ATG9B FRAS1 DGKD TG EIF4G2 GABRA6 | 1.29e-03 | 619 | 260 | 14 | EFO_0003923, EFO_0004531 |
| Disease | breast cancer (is_marker_for) | 1.32e-03 | 185 | 260 | 7 | DOID:1612 (is_marker_for) | |
| Disease | cholesteryl ester measurement, intermediate density lipoprotein measurement | 1.48e-03 | 94 | 260 | 5 | EFO_0008595, EFO_0010351 | |
| Disease | sleep duration | KDM3B SLC7A11 FAM3D TENM2 PTPRJ SH3RF1 CTC1 PRC1 PRKG2 ZMYM4 | 1.50e-03 | 362 | 260 | 10 | EFO_0005271 |
| Disease | ovarian cancer (is_implicated_in) | 1.51e-03 | 56 | 260 | 4 | DOID:2394 (is_implicated_in) | |
| Disease | psychosis predisposition measurement | 1.51e-03 | 26 | 260 | 3 | EFO_0008337 | |
| Disease | chronic mucus hypersecretion | 1.58e-03 | 7 | 260 | 2 | EFO_0005673 | |
| Disease | Gonadal dysgenesis XX type deafness | 1.58e-03 | 7 | 260 | 2 | C0685838 | |
| Disease | grapefruit juice consumption measurement | 1.58e-03 | 7 | 260 | 2 | EFO_0010094 | |
| Disease | lifestyle measurement, diastolic blood pressure | 1.58e-03 | 7 | 260 | 2 | EFO_0006336, EFO_0010724 | |
| Disease | Hypertrophic Cardiomyopathy | 1.61e-03 | 57 | 260 | 4 | C0007194 | |
| Disease | free cholesterol to total lipids in medium VLDL percentage | 1.61e-03 | 57 | 260 | 4 | EFO_0022284 | |
| Disease | triglycerides to total lipids in small VLDL percentage | 1.72e-03 | 58 | 260 | 4 | EFO_0022338 | |
| Disease | total cholesterol measurement, intermediate density lipoprotein measurement | 1.86e-03 | 99 | 260 | 5 | EFO_0004574, EFO_0008595 | |
| Disease | phospholipid measurement, intermediate density lipoprotein measurement | 1.86e-03 | 99 | 260 | 5 | EFO_0004639, EFO_0008595 | |
| Disease | mean platelet volume | MYL4 TBC1D5 SRCAP PICALM SVEP1 PTPRJ ADGRF3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA5 PCDHGA1 SMURF1 DDO MACROH2A1 PRC1 DOCK7 ESPL1 CUX1 | 1.87e-03 | 1020 | 260 | 19 | EFO_0004584 |
| Disease | intraocular pressure measurement | ABCA1 ABCA4 MAPK8IP3 PTPRJ GNL2 PKHD1 FBXO32 MXRA5 PCDHGA5 RALYL EFHC2 ABCA6 | 2.00e-03 | 509 | 260 | 12 | EFO_0004695 |
| Disease | cognitive function measurement | DENND4A HIVEP1 AFTPH PDLIM7 TBC1D5 BIRC6 GALNT18 PKHD1 LRRC7 MYO18B USH2A REV1 GPD2 CACNA1C PCDHGA5 CEP192 TFDP2 PDIA6 KMT2D TENM4 AP3B2 RIMBP2 TMEM131 HYDIN | 2.07e-03 | 1434 | 260 | 24 | EFO_0008354 |
| Disease | severe pre-eclampsia (is_marker_for) | 2.09e-03 | 8 | 260 | 2 | DOID:13129 (is_marker_for) | |
| Disease | pantothenate measurement | 2.09e-03 | 8 | 260 | 2 | EFO_0021034 | |
| Disease | Sudden Cardiac Death | 2.09e-03 | 8 | 260 | 2 | C0085298 | |
| Disease | free cholesterol measurement, intermediate density lipoprotein measurement | 2.31e-03 | 104 | 260 | 5 | EFO_0008591, EFO_0008595 | |
| Disease | oral squamous cell carcinoma (is_marker_for) | 2.33e-03 | 63 | 260 | 4 | DOID:0050866 (is_marker_for) | |
| Disease | triglycerides to total lipids in medium VLDL percentage | 2.33e-03 | 63 | 260 | 4 | EFO_0022335 | |
| Disease | cholesterol to total lipids in medium VLDL percentage | 2.33e-03 | 63 | 260 | 4 | EFO_0022239 | |
| Disease | acoustic startle blink response measurement | 2.67e-03 | 9 | 260 | 2 | EFO_0006875 | |
| Disease | low tension glaucoma | 2.67e-03 | 9 | 260 | 2 | EFO_1001022 | |
| Disease | Mental deterioration | 2.67e-03 | 9 | 260 | 2 | C0234985 | |
| Disease | chymotrypsin-like elastase family member 2A measurement | 2.67e-03 | 9 | 260 | 2 | EFO_0802399 | |
| Disease | Mild cognitive disorder | 2.67e-03 | 9 | 260 | 2 | C1270972 | |
| Disease | MYELODYSPLASTIC SYNDROME | 2.92e-03 | 67 | 260 | 4 | C3463824 | |
| Disease | pulse pressure measurement | MYL4 MRPS27 SRCAP LARP4 SVEP1 DIP2A CLCN6 FBXO32 BORCS7 FLNB MXRA5 FAT3 PCDHA13 CELA2B TBL1XR1 CCNA2 TENM4 CSNK1G3 SLIT3 MBD5 CNOT1 HYDIN GABRA6 | 3.00e-03 | 1392 | 260 | 23 | EFO_0005763 |
| Disease | psoriasis | 3.05e-03 | 273 | 260 | 8 | EFO_0000676 | |
| Disease | obesity (implicated_via_orthology) | 3.08e-03 | 215 | 260 | 7 | DOID:9970 (implicated_via_orthology) | |
| Disease | free cholesterol measurement | 3.31e-03 | 113 | 260 | 5 | EFO_0008591 | |
| Disease | leptin measurement, sex interaction measurement | 3.32e-03 | 10 | 260 | 2 | EFO_0005000, EFO_0008343 | |
| Disease | Methylmalonic acidemia | 3.32e-03 | 10 | 260 | 2 | C0268583 | |
| Disease | glucagon-like peptide-1 measurement | 3.32e-03 | 10 | 260 | 2 | EFO_0008465 | |
| Disease | level of Phosphatidylcholine (16:0_20:3) in blood serum | 3.32e-03 | 10 | 260 | 2 | OBA_2045075 | |
| Disease | morbid obesity (is_marker_for) | 3.32e-03 | 10 | 260 | 2 | DOID:11981 (is_marker_for) | |
| Disease | response to carboplatin, response to antineoplastic agent | 3.32e-03 | 10 | 260 | 2 | GO_0097327, GO_0097328 | |
| Disease | creatinine measurement | SIPA1L3 OBSCN BIRC6 PTPRJ PKHD1 TP53RK POR CELA2B CUBN TFDP2 CCNA2 G3BP1 AP3B2 DOCK7 LRP2 DIP2C MBD5 CUX1 | 3.33e-03 | 995 | 260 | 18 | EFO_0004518 |
| Disease | hair colour measurement | MYL4 ZFYVE16 LGR4 KCNH1 PKHD1 FRAS1 RASA3 ADAMTS1 PPM1A RALY KMT2D TENM4 SLC7A5 | 3.39e-03 | 615 | 260 | 13 | EFO_0007822 |
| Disease | total cholesterol measurement, low density lipoprotein cholesterol measurement | 3.44e-03 | 114 | 260 | 5 | EFO_0004574, EFO_0004611 | |
| Disease | free cholesterol in small HDL measurement | 3.59e-03 | 35 | 260 | 3 | EFO_0022270 | |
| Disease | Methylmalonic aciduria | 4.04e-03 | 11 | 260 | 2 | C1855119 | |
| Disease | N-acetylphenylalanine measurement | 4.04e-03 | 11 | 260 | 2 | EFO_0800019 | |
| Disease | X-11315 measurement | 4.04e-03 | 11 | 260 | 2 | EFO_0021223 | |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 4.18e-03 | 74 | 260 | 4 | DOID:3748 (is_marker_for) | |
| Disease | sleep latency | 4.21e-03 | 37 | 260 | 3 | EFO_0005280 | |
| Disease | metabolite measurement | PDXDC1 ACY3 SRSF12 ITPR2 PNP GLYATL3 POR GBA3 GSTP1 SLC6A20 RIMBP2 CSMD1 | 4.32e-03 | 560 | 260 | 12 | EFO_0004725 |
| Disease | free cholesterol to total lipids in small VLDL percentage | 4.39e-03 | 75 | 260 | 4 | EFO_0022287 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 4.47e-03 | 291 | 260 | 8 | EFO_0008317, EFO_0020946 | |
| Disease | level of Phosphatidylinositol (16:0_18:1) in blood serum | 4.82e-03 | 12 | 260 | 2 | OBA_2045152 | |
| Disease | level of Phosphatidylinositol (18:0_20:3) in blood serum | 4.82e-03 | 12 | 260 | 2 | OBA_2045157 | |
| Disease | interferon alpha measurement | 4.82e-03 | 12 | 260 | 2 | EFO_0006517 | |
| Disease | autoimmune thyroiditis (is_implicated_in) | 4.82e-03 | 12 | 260 | 2 | DOID:7188 (is_implicated_in) | |
| Disease | cleft palate (is_implicated_in) | 4.82e-03 | 12 | 260 | 2 | DOID:674 (is_implicated_in) | |
| Disease | cortical thickness | ABCA4 TBC1D5 LGR4 WLS TENM2 STAT1 MAPK8IP3 PKHD1 MTCL1 FLNB FAT3 TFDP2 TG EFNB2 G3BP1 SETD5 DOCK7 TMEM131 PTPN20 | 4.83e-03 | 1113 | 260 | 19 | EFO_0004840 |
| Disease | Cleft upper lip | 4.89e-03 | 39 | 260 | 3 | C0008924 | |
| Disease | docosahexaenoic acid measurement | 5.44e-03 | 127 | 260 | 5 | EFO_0007761 | |
| Disease | Malignant Neoplasms | 5.62e-03 | 128 | 260 | 5 | C0006826 | |
| Disease | Depression, Neurotic | 5.63e-03 | 41 | 260 | 3 | C0282126 | |
| Disease | Melancholia | 5.63e-03 | 41 | 260 | 3 | C0025193 | |
| Disease | squamous cell carcinoma, multiple keratinocyte carcinoma susceptibility measurement, basal cell carcinoma | 5.66e-03 | 13 | 260 | 2 | EFO_0000707, EFO_0004193, EFO_0007932 | |
| Disease | level of Phosphatidylinositol (18:1_18:1) in blood serum | 5.66e-03 | 13 | 260 | 2 | OBA_2045159 | |
| Disease | cortisol measurement, response to corticosteroid, response to synacthen | 5.66e-03 | 13 | 260 | 2 | EFO_0005843, EFO_0009175, GO_0031960 | |
| Disease | intercellular adhesion molecule 5 measurement | 5.66e-03 | 13 | 260 | 2 | EFO_0008164 | |
| Disease | tea consumption measurement | 5.80e-03 | 129 | 260 | 5 | EFO_0010091 | |
| Disease | Depressive Syndrome | 6.03e-03 | 42 | 260 | 3 | C0086133 | |
| Disease | Autoimmune Diseases | 6.03e-03 | 42 | 260 | 3 | C0004364 | |
| Disease | polyunsaturated fatty acid measurement | 6.19e-03 | 131 | 260 | 5 | EFO_0010733 | |
| Disease | Alzheimer's disease (is_implicated_in) | 6.38e-03 | 132 | 260 | 5 | DOID:10652 (is_implicated_in) | |
| Disease | free cholesterol to total lipids in very small VLDL percentage | 6.44e-03 | 43 | 260 | 3 | EFO_0022290 | |
| Disease | Metabolic Bone Disorder | 6.56e-03 | 14 | 260 | 2 | C0005944 | |
| Disease | membranous glomerulonephritis (biomarker_via_orthology) | 6.56e-03 | 14 | 260 | 2 | DOID:10976 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PDFGNIGIVQKSSLR | 561 | Q8NAT2 | |
| RLQGTQGAKEAPLQR | 471 | Q15173 | |
| QGTVKPTFRNGSQTL | 436 | Q96MC4 | |
| SGNLAIIRVPNKVNG | 451 | Q7L0X2 | |
| TGKQQVSPIRNLSDG | 506 | Q9UG63 | |
| AAASKGPGVLQNLFQ | 2141 | Q9P281 | |
| LFTRTKLLQAGQGSP | 486 | Q8IZF5 | |
| ANAKFNLQLVGPRGI | 391 | Q96JP9 | |
| LNQLLGPKASGQAFD | 96 | Q96HD9 | |
| AQPLLGNGSANIKLV | 86 | Q92870 | |
| FQTGQGPLDAQVKLL | 2826 | Q9NR09 | |
| GNLKVRLSGFQLPSS | 96 | Q96PZ7 | |
| RGAVLLQSFSRQKPG | 426 | Q2NKJ3 | |
| VVKGSVFLRNPSRNN | 51 | P0C0L5 | |
| GNPTVKDFLNRQLGE | 456 | P78363 | |
| QILENRNGSLKPGSS | 166 | Q06187 | |
| NERISGLGLTPEQKQ | 96 | O95831 | |
| LSSENNPLVQFKEGG | 946 | Q86TB3 | |
| TNRGFSVEKQGLPTL | 306 | Q6ULP2 | |
| KQQAARLAQGVGPLA | 6 | A6NKF2 | |
| LFQEVPKRRNGSEGN | 641 | P39880 | |
| QNLSGGQNRKLTFGI | 616 | Q8IUA7 | |
| AKALRSLQFTNPGRQ | 146 | Q8N8R7 | |
| QLSGTLQIKPGVFNE | 41 | Q9NZJ6 | |
| SGRNGFPKQTAAQLI | 316 | O75367 | |
| PGVVGNFNKSIVARL | 91 | O95477 | |
| PQNLGRVDKFNSSSL | 61 | Q8N139 | |
| QRQGNGTFVQTDKPL | 116 | A8K2U0 | |
| NQLDVGNNPRVGTKR | 366 | Q04771 | |
| GNVLPTADIAQFKQG | 481 | Q8N6H7 | |
| NAVGPSNVRFSVQKG | 266 | Q96K78 | |
| NKKNAGFTPQERQGF | 226 | P27695 | |
| SGLTVEQFRKINGFP | 276 | O43286 | |
| NFLTENPSGIKGISR | 226 | Q8IWE4 | |
| VNGQRGENSKLSLTP | 286 | Q8IZT6 | |
| SISTFQRGLKDPNQL | 111 | Q13367 | |
| GKFSTLLQNLGPENA | 391 | Q7Z401 | |
| IGALQKNPSLGVSNT | 116 | P26374 | |
| LQRPLQSFGQTGKRS | 56 | Q15032 | |
| RNNGNGLVKFLSPQD | 341 | Q9NTZ6 | |
| PKSINSRVFIGNLNT | 16 | Q86SE5 | |
| PKSINSRVFIGNLNT | 16 | Q9UKM9 | |
| DRKLGTFLQTNPTGN | 291 | Q5RL73 | |
| KRTQDPNTIFRGNSL | 361 | Q14644 | |
| IPQGSSLVLQGNSKR | 1551 | A6NNM3 | |
| IPQGSSLVLQGNSKR | 1551 | A6NJZ7 | |
| LAPGFTLQNVGRKSG | 96 | Q9UHI8 | |
| DPSGGNKVLLLSIQN | 161 | Q8WVV9 | |
| EQLQKENSPRRGGSF | 1271 | Q9Y4B5 | |
| IPGSNATLTNAAGKR | 896 | Q9Y5G8 | |
| GKTQLFAVNPRSGSL | 71 | Q9Y5H2 | |
| KQRLGFLGSNTPHVN | 2681 | Q14571 | |
| RQIIFSSLFSPQGNK | 91 | Q96N11 | |
| SGARPKVLTGNLNVQ | 176 | Q9UPP5 | |
| PGKNVTLLCQSRGQF | 336 | Q8N149 | |
| GRINPGNNILEFKTQ | 1706 | Q8N7Z5 | |
| FLLPSAQGRQKESGS | 16 | Q8NBL1 | |
| PGSRKFNTTERVLQG | 13031 | Q8WXI7 | |
| RVLQGLLGPLFKNSS | 13041 | Q8WXI7 | |
| LQGLLRPVFKNTSVG | 13511 | Q8WXI7 | |
| QDSRLQVNISGLKPG | 251 | Q12913 | |
| TNPFGKGAFIQLLRQ | 286 | Q13823 | |
| SPVKNNVGRGLNIAL | 91 | Q96BQ1 | |
| PTNGQLVLSRNGKEV | 1146 | Q86XX4 | |
| KGPIRSFTQADISQG | 2141 | Q86XX4 | |
| NLKAGPSRTVGLFLQ | 456 | P43304 | |
| PTQGIVNKAFGINTD | 366 | Q9UPT6 | |
| LPGRGQLQKLASERN | 261 | P42166 | |
| NSIPLTATNFRIQGK | 936 | Q6P4R8 | |
| PFLAAVTTNRKLNQG | 281 | P16435 | |
| KEREGTLAQQAAGPQ | 341 | Q96T17 | |
| SNLLQPGDKILQANG | 1491 | Q96NW7 | |
| TLQQFPGGSIDLQKE | 46 | Q9NTX5 | |
| RDNPSERLGNLKNGV | 596 | Q13976 | |
| LQPGNALKRFLTSQT | 346 | Q8N1G4 | |
| LQLQESGSGLVKPSQ | 21 | A0A087WSY4 | |
| NTNAGFTARLKNLPS | 146 | O43451 | |
| DPNIGKRLNALGNTL | 3461 | Q2LD37 | |
| GLGSQNIIDLTNKDP | 146 | Q8WX39 | |
| ATVQNRFTKNLPSGE | 826 | Q8IY21 | |
| NSSNSKFLPGQGLVL | 36 | P52799 | |
| SGRAIPNNQVLGKIE | 111 | O60869 | |
| LPGNSFNRNVGKEKF | 6 | Q5JST6 | |
| KVNQPASFAIRLNGA | 2301 | O75369 | |
| TQGNGTRDQKLDTFP | 216 | Q1X8D7 | |
| QPGNRASKDQGKFLT | 261 | Q9Y3N9 | |
| IPGSNATLTNAAGKR | 901 | Q9Y5H3 | |
| IPGSNATLTNAAGKR | 896 | Q9Y5G2 | |
| TIVSGNNKGLFRIDP | 716 | Q9HC56 | |
| NNKGLFRIDPVTGNI | 721 | Q9HC56 | |
| NAIRGLPGSFIKEVQ | 276 | A8MUH7 | |
| SLNNSNIPRFGVKTD | 346 | P27815 | |
| FSPVQALQKGRTFNL | 651 | Q6P996 | |
| QVGKRQPRSNGDFLA | 171 | P22794 | |
| RQSPKGLDAATFQNV | 996 | Q1MSJ5 | |
| PDLQGRFELSGKNRQ | 71 | Q6P2I7 | |
| KPNLVNGLQARTFGI | 41 | Q9UKR5 | |
| QSNGVLATENKPLGF | 491 | Q7LBC6 | |
| SRGVLQQLAPSVQKG | 161 | O95259 | |
| FVQIGKGDVSNLDPN | 216 | Q01650 | |
| QSPTLVGGALLDQNK | 321 | Q14693 | |
| QSIGLIQPFATNGKL | 146 | Q9UIQ6 | |
| TSFPTEGLNGLNQLK | 426 | Q9BXB1 | |
| APALGGQQSVSNKLL | 386 | Q71SY5 | |
| LGNPNGEKLFQNLRT | 466 | Q6X4W1 | |
| RLKFGGPTEILSLNN | 91 | Q16445 | |
| VLRNRAQSGSVPQFK | 1736 | P00451 | |
| SLVKPSENGNGVTFR | 4466 | P98164 | |
| GQNPTNAEVLRVLGK | 86 | P12829 | |
| QGPKANILVSGNEIR | 251 | Q8NAT1 | |
| PSSQAGLNQKLNFIV | 31 | Q9BTT4 | |
| FGLLSKNNRFGRNPV | 296 | O43934 | |
| GKLVGRNPNTNLEAL | 126 | Q9NY56 | |
| AEGQPGQKQSTTFRR | 151 | P78344 | |
| RIGLNLFNINPDKGI | 656 | Q9UPP2 | |
| ENFLIGRPGNKTQQV | 166 | Q9Y6M4 | |
| FRLQGGKDFNVPLSI | 16 | Q9NR12 | |
| PTERLGNLKNGINDI | 691 | Q13237 | |
| GQTLQFKLRLDLPSG | 611 | Q8NBF2 | |
| NKGNLRSAITIFPQR | 456 | P29475 | |
| AGDSKIFPVRGQVLQ | 191 | Q99489 | |
| NPNNGEIRTKGKLDF | 296 | Q9Y5I0 | |
| GLENEQFKSPGNRVS | 651 | Q8WY54 | |
| GTGLLLTLQPEQKFQ | 101 | P04062 | |
| GNKFQTLSEPRSGLL | 6151 | Q5VST9 | |
| TIQGELNAPTQFKGR | 416 | Q7Z3B4 | |
| LELKNLPGEFNSGNQ | 166 | Q4JDL3 | |
| GSRPGKNVQLTENEI | 21 | P62136 | |
| FNPENKQKGILLTGS | 706 | Q460N5 | |
| RKLQSRGFPSQGNVL | 236 | Q5SZD4 | |
| IRQGLNKNLGFSPED | 91 | O43252 | |
| SQFRGNETGLITPNK | 956 | P38398 | |
| KGSAIGLPQNISSQI | 96 | O60494 | |
| RTQNLFEKLQSTPGA | 351 | Q8IZD4 | |
| RSKFDKNGQPLSGNE | 596 | P87889 | |
| RSKFDKNGQPLSGNE | 596 | Q9YNA8 | |
| RSKFDKNGQPLSGNE | 596 | P62683 | |
| RSKFDKNGQPLSGNE | 596 | P63145 | |
| RSKFDKNGQPLSGNE | 596 | Q7LDI9 | |
| RSKFDKNGQPLSGNE | 596 | P63130 | |
| RSKFDKNGQPLSGNE | 596 | P62685 | |
| RSKFDKNGQPLSGNE | 596 | P63126 | |
| RSKFDKNGQPLSGNE | 596 | P62684 | |
| GAGLPQFQSISLRKI | 211 | P51797 | |
| EFPRNNLQFGKTLGA | 576 | P07333 | |
| APLRLNNTSQKGLEG | 1326 | Q14674 | |
| IGGKNLRTFTILNPT | 3991 | Q4G0P3 | |
| GLVGKPSQRNALSLQ | 1686 | Q13936 | |
| QKGLPRQVFEQDASG | 146 | Q96HP0 | |
| QNGRLKTGQFCLPVS | 676 | Q96N67 | |
| GRLQTNGALPDDLKQ | 161 | P08218 | |
| SRLLPDGTTGFINQK | 81 | Q9H227 | |
| ENNPRTGNLGALIKV | 66 | Q7RTS9 | |
| GSHPFGKSLQRQANI | 771 | O75460 | |
| GLTPFTVTTKNQNRG | 1711 | Q9Y6R7 | |
| VVELRINSGGKLPNF | 366 | Q13283 | |
| SSLQREPFTIAQGKG | 71 | P35659 | |
| QIQNVSKSGGFPRID | 1071 | A8TX70 | |
| PGSDRASFIKNLQGI | 111 | P12110 | |
| LNKSNGIPFRNLRGS | 4201 | Q8TDW7 | |
| GSPLAKARGQNVTIF | 76 | Q2M3T9 | |
| QFSQGGPIQNRKSKR | 556 | Q6P9A2 | |
| FGSAKQLVRGEPNVS | 201 | P49841 | |
| VKGFVRDLQGNPIAN | 376 | P16870 | |
| PLTRKDAGSQQIGFL | 416 | Q9Y2E4 | |
| QLKPFETLLSQNQGG | 126 | P09211 | |
| EKLGQQVNRTCPGFL | 161 | Q8J025 | |
| TQKARNLFPGGFQVT | 896 | Q674R7 | |
| TPESQARFGQSVKGL | 6 | Q96B45 | |
| LLNGQKLQGPETARE | 291 | P21695 | |
| DGGPQDQLKNAISSI | 186 | Q12967 | |
| QKNRVKPQFRSSGGS | 371 | Q71RC2 | |
| DLLRKQGQGSFPISS | 686 | Q9P267 | |
| EKGGIQQVKGPFRSN | 181 | P38484 | |
| QQVKGPFRSNSISLD | 186 | P38484 | |
| EKGFKLPTNGLRQAN | 251 | Q8TEP8 | |
| SRNLAPKGRNSENIF | 206 | Q8WXU2 | |
| PLLVFVNSKSGDNQG | 321 | Q16760 | |
| KVIQSQDGFPAGQEL | 476 | Q08554 | |
| PLTRKDAGSQQVGFL | 431 | Q14689 | |
| AVLKSGNPRGLAQQQ | 51 | P20248 | |
| GAPVQSQGSQNKLLL | 21 | Q6UWV6 | |
| NKAGISFIINRPFLG | 171 | Q86UP8 | |
| NKAGISFIINRPFLG | 171 | Q6EKJ0 | |
| NNIQITRPAFKGLTF | 211 | Q969P5 | |
| QLQLDGNGKLRSQAP | 526 | Q86YV9 | |
| SPQGAGLVIQKNLSA | 281 | Q9NZM4 | |
| KLPSFVAQANRAQGQ | 51 | Q8N4W6 | |
| NIGNLRKLGNFTKPE | 796 | Q9Y2H2 | |
| KNQDITLFPRGGVAA | 2841 | Q9NZJ4 | |
| QEVNGTLPLIKFNGA | 3671 | Q9NZJ4 | |
| FEGATKRNRPNVQVG | 146 | Q9NQT5 | |
| LVVTNAAGGLNPKFE | 111 | P00491 | |
| KEGGPFKALLRQQTQ | 326 | Q86YS7 | |
| VSGKRVVNPASAFQG | 536 | O43781 | |
| VVKGSVFLRNPSRNN | 51 | P0C0L4 | |
| RGDKTNQGIPELNAS | 186 | P46019 | |
| QGFPTIKIFGSNKNR | 96 | Q15084 | |
| QSRNQKPRGTLQLAG | 96 | Q9BXB4 | |
| IPGSNATLTNAAGKR | 896 | Q9Y5H4 | |
| GKPGRVNQTTVSDFL | 16 | Q8NGR9 | |
| NTNLSKGDARGQPKV | 41 | Q9NQT8 | |
| SAKDVPTGGIFQLRQ | 1011 | Q9NQT8 | |
| ERNFGASLLLPGLKQ | 201 | Q92552 | |
| PSGLRNFIVEQKENG | 4066 | O75445 | |
| ELNGQKGLVPSNFLE | 1001 | O15034 | |
| VLEKVPAGNRASNQG | 476 | Q8WZA2 | |
| RQRGDQLVPFSTKSG | 266 | Q9BTV4 | |
| EPGNVENNGVLSFIK | 251 | P54577 | |
| EQKNAGTRTNEGPLI | 411 | P42224 | |
| RPDKQNLFAIIQGGL | 191 | Q9BXR0 | |
| GLQRDLPGKQAQLSR | 576 | Q6ZMZ3 | |
| QGLIKGQTFRLPSGQ | 596 | Q15031 | |
| RSKEKNPGNQGRQFD | 741 | Q5JRA6 | |
| IPQGSSLVLQGNSKR | 1551 | Q9UFD9 | |
| AGGRLSPENNQVLTK | 46 | Q16514 | |
| GLQLNVKERSFGPLT | 191 | O15197 | |
| GQFSAVPLNLIGLKA | 81 | Q9Y617 | |
| RNKVSRIPQGTFSNL | 151 | O60938 | |
| KASDPNRFTNRGGNL | 371 | O43663 | |
| TNTKNVFGQPRLRAS | 1481 | O60292 | |
| RLQPLQGSGVKTQTG | 1426 | Q9C0A6 | |
| QKSGIGDRPLQDLSN | 1206 | Q562F6 | |
| GQTSPKQENGTLALL | 656 | Q96NU1 | |
| KGTGENQFLTQQPAI | 1196 | Q9NT68 | |
| LNPLVTLGGNKESFQ | 156 | Q9BQG2 | |
| TLGGNKESFQQPEVR | 161 | Q9BQG2 | |
| RGLPKNSFNISNLLV | 281 | P51888 | |
| QTPQVLRFFLLGNKS | 3476 | P08F94 | |
| PLTFQIQGNKLTLTG | 1206 | Q6ZRS2 | |
| LNGKADIENRTTGPN | 3306 | Q4LDE5 | |
| QKSALAFLNRGQPSS | 121 | Q9H0H5 | |
| RKTLNISPSLQENGG | 151 | Q9NP91 | |
| IEIQFAQGDRKTPGQ | 81 | Q8WXF0 | |
| RGFIDQNLSPTKGNI | 16 | Q14188 | |
| LGQDRPIKTFQGHTN | 336 | Q9BZK7 | |
| GGSQARFLLSKVNPS | 711 | Q15436 | |
| RVPLQGFKALQGSTG | 686 | Q9HCE7 | |
| AKNQIGNSELPGSLE | 216 | Q5VX52 | |
| RSKFDKNGQPLSGNE | 596 | P63128 | |
| LQRNGKTGLFPGSFV | 871 | Q7Z6J0 | |
| QANPLKGDLANTFRG | 101 | Q6UW56 | |
| NDPFVQRKLGTSGLN | 801 | A5YKK6 | |
| QRKLGTSGLNQPTFQ | 806 | A5YKK6 | |
| GGLLKPTVASQNQNL | 511 | Q13492 | |
| SENQIQGIPRKAFRG | 141 | O75094 | |
| TGSSRVPLQGFKALQ | 676 | Q9HAU4 | |
| LQGNVNGRLPSLGNK | 16 | Q9UPY5 | |
| LGFVGPLKSQAADQI | 211 | Q96I99 | |
| NGELKVFIDQNLSPG | 11 | Q14186 | |
| LQQVPELKNRIFSGG | 296 | Q9HA65 | |
| RNLQSEVKIANNPGG | 66 | Q6PDB4 | |
| KENFNPTTGILVIGN | 186 | Q86XK7 | |
| AFNVKPQGSRLDLFG | 46 | Q99797 | |
| VDLEQTSPGRKQNGI | 201 | Q9UBZ9 | |
| TPLNNLGFSRKGSAL | 436 | Q8WVR3 | |
| APSVENVKNGIRTGF | 91 | P35813 | |
| SFFQNRKILPGGNTS | 156 | Q92545 | |
| GKRNVTLPIDNGLNL | 1796 | Q6N022 | |
| RGKLVQVNSRFNSPT | 281 | P41221 | |
| VGINVPTNDLNLKFG | 846 | Q6AHZ1 | |
| ANGDIKGRKPFTNQR | 1131 | Q9UBS9 | |
| PLNTGLFRIKIQGAT | 1396 | Q86X10 | |
| KIQLNDLERNPTGGA | 1501 | Q8IUG5 | |
| LLQKLTSPDVGGNDQ | 306 | P41587 | |
| TASGPEGNVRNLQKR | 11 | Q8N9V7 | |
| GKDFLPRSGLLQQEA | 176 | E7ETH6 | |
| RGNLGLIPRSTAFQK | 6 | Q9P0L1 | |
| KTSNIFGLQRIFPAG | 486 | Q9UPP1 | |
| PQGLSNLAKTIGQVL | 136 | Q96S44 | |
| VNTVFEQPGKNINGR | 1106 | Q5TAH2 | |
| TNIPLTKQGGSRDVQ | 1051 | Q9H7P9 | |
| PLNINKVSNSLINFG | 451 | Q92609 | |
| AGNKPITNQLGLTFQ | 101 | Q5HY98 | |
| FQVFRNISGKQSSLP | 401 | Q5T9L3 | |
| PGNLTGFLVQRKASA | 626 | P0DP72 | |
| IGLRQKNSFKQSGPS | 11 | Q14679 | |
| GTNKDFPQNAIRQRS | 256 | Q9H3N1 | |
| TTNPKRLQQNLFGGK | 461 | P01266 | |
| GGFQPVNIKAARQDL | 421 | O95185 | |
| PVNQTAASNKGLRGL | 546 | Q6PJT7 | |
| SNPIQDGLRKAGATQ | 1086 | Q702N8 | |
| QEQQGKLLSPRSLGS | 656 | P15822 | |
| NTVRTPEENGNLGKI | 791 | Q14202 | |
| SFDPLNKGQGIQARS | 1146 | Q5VZL5 | |
| NDLRAGQFGISARKP | 671 | O95405 | |
| GKDFLPRSGLLQQEA | 176 | B7Z6K7 | |
| SQSVGGARPKQLFSL | 641 | Q7Z3T8 | |
| NERGINFSRKSPLTQ | 56 | Q4V348 | |
| LQFRLGPTLQGKAVT | 31 | P35573 | |
| QLSRGQTPFAGTQDK | 2731 | O14686 | |
| DGGSQLILEKFQLPQ | 301 | Q9NR99 | |
| KLAGPGQRETSQRFS | 1706 | B2RTY4 | |
| QFISRGTFNPEKGKQ | 2486 | B2RTY4 | |
| NGSLPKGVEAQNRTL | 286 | Q15223 |